id	sid	tid	token	lemma	pos
fnp-3388	1	1	association	association	PROPN
fnp-3388	1	2	of	of	ADP
fnp-3388	1	3	acute	acute	PROPN
fnp-3388	1	4	disseminated	disseminate	VERB
fnp-3388	1	5	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	1	6	(	(	PUNCT
fnp-3388	1	7	adem	adem	PROPN
fnp-3388	1	8	)	)	PUNCT
fnp-3388	1	9	and	and	CCONJ
fnp-3388	1	10	covid-19	covid-19	PROPN
fnp-3388	1	11	in	in	ADP
fnp-3388	1	12	a	a	DET
fnp-3388	1	13	pediatric	pediatric	ADJ
fnp-3388	1	14	patient	patient	NOUN
fnp-3388	1	15	feel	feel	VERB
fnp-3388	1	16	free	free	ADJ
fnp-3388	1	17	to	to	PART
fnp-3388	1	18	add	add	VERB
fnp-3388	1	19	comments	comment	NOUN
fnp-3388	1	20	by	by	ADP
fnp-3388	1	21	clicking	click	VERB
fnp-3388	1	22	these	these	DET
fnp-3388	1	23	icons	icon	NOUN
fnp-3388	1	24	on	on	ADP
fnp-3388	1	25	the	the	DET
fnp-3388	1	26	sidebar	sidebar	NOUN
fnp-3388	1	27	free	free	ADJ
fnp-3388	1	28	neuropathology	neuropathology	NOUN
fnp-3388	1	29	2:19	2:19	NUM
fnp-3388	1	30	(	(	PUNCT
fnp-3388	1	31	2021	2021	NUM
fnp-3388	1	32	)	)	PUNCT
fnp-3388	1	33	case	case	NOUN
fnp-3388	1	34	report	report	NOUN
fnp-3388	1	35	association	association	NOUN
fnp-3388	1	36	of	of	ADP
fnp-3388	1	37	acute	acute	PROPN
fnp-3388	1	38	disseminated	disseminate	VERB
fnp-3388	1	39	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	1	40	(	(	PUNCT
fnp-3388	1	41	adem	adem	PROPN
fnp-3388	1	42	)	)	PUNCT
fnp-3388	1	43	and	and	CCONJ
fnp-3388	1	44	covid-19	covid-19	PROPN
fnp-3388	1	45	in	in	ADP
fnp-3388	1	46	a	a	DET
fnp-3388	1	47	pediatric	pediatric	ADJ
fnp-3388	1	48	patient	patient	NOUN
fnp-3388	1	49	liam	liam	PROPN
fnp-3388	1	50	chen	chen	PROPN
fnp-3388	1	51	department	department	PROPN
fnp-3388	1	52	of	of	ADP
fnp-3388	1	53	laboratory	laboratory	NOUN
fnp-3388	1	54	medicine	medicine	NOUN
fnp-3388	1	55	and	and	CCONJ
fnp-3388	1	56	pathology	pathology	NOUN
fnp-3388	1	57	,	,	PUNCT
fnp-3388	1	58	university	university	PROPN
fnp-3388	1	59	of	of	ADP
fnp-3388	1	60	minnesota	minnesota	PROPN
fnp-3388	1	61	medical	medical	PROPN
fnp-3388	1	62	school	school	PROPN
fnp-3388	1	63	,	,	PUNCT
fnp-3388	1	64	minneapolis	minneapolis	PROPN
fnp-3388	1	65	,	,	PUNCT
fnp-3388	1	66	mn	mn	PROPN
fnp-3388	1	67	,	,	PUNCT
fnp-3388	1	68	usa	usa	PROPN
fnp-3388	1	69	corresponding	corresponding	PROPN
fnp-3388	1	70	author	author	NOUN
fnp-3388	1	71	:	:	PUNCT
fnp-3388	1	72	liam	liam	PROPN
fnp-3388	1	73	chen	chen	PROPN
fnp-3388	1	74	·	·	PUNCT
fnp-3388	1	75	department	department	PROPN
fnp-3388	1	76	of	of	ADP
fnp-3388	1	77	laboratory	laboratory	NOUN
fnp-3388	1	78	medicine	medicine	NOUN
fnp-3388	1	79	and	and	CCONJ
fnp-3388	1	80	pathology	pathology	NOUN
fnp-3388	1	81	·	·	PUNCT
fnp-3388	1	82	university	university	PROPN
fnp-3388	1	83	of	of	ADP
fnp-3388	1	84	minnesota	minnesota	PROPN
fnp-3388	1	85	medical	medical	PROPN
fnp-3388	1	86	school	school	NOUN
fnp-3388	1	87	·	·	PUNCT
fnp-3388	1	88	c515	c515	PROPN
fnp-3388	1	89	mayo	mayo	VERB
fnp-3388	1	90	memorial	memorial	ADJ
fnp-3388	1	91	building	building	NOUN
fnp-3388	1	92	·	·	PUNCT
fnp-3388	1	93	420	420	NUM
fnp-3388	1	94	delaware	delaware	PROPN
fnp-3388	1	95	street	street	PROPN
fnp-3388	1	96	·	·	PUNCT
fnp-3388	1	97	minneapolis	minneapolis	PROPN
fnp-3388	1	98	,	,	PUNCT
fnp-3388	1	99	mn	mn	PROPN
fnp-3388	1	100	55455	55455	NUM
fnp-3388	1	101	·	·	PUNCT
fnp-3388	1	102	usa	usa	PROPN
fnp-3388	1	103	llchen@umn.edu	llchen@umn.edu	PROPN
fnp-3388	1	104	submitted	submit	VERB
fnp-3388	1	105	:	:	PUNCT
fnp-3388	1	106	8	8	NUM
fnp-3388	1	107	june	june	PROPN
fnp-3388	1	108	2021	2021	NUM
fnp-3388	1	109	accepted	accept	VERB
fnp-3388	1	110	:	:	PUNCT
fnp-3388	1	111	8	8	NUM
fnp-3388	1	112	july	july	PROPN
fnp-3388	1	113	2021	2021	NUM
fnp-3388	1	114	copyedited	copyedit	VERB
fnp-3388	1	115	by	by	ADP
fnp-3388	1	116	:	:	PUNCT
fnp-3388	1	117	deborah	deborah	PROPN
fnp-3388	1	118	mcintyre	mcintyre	PROPN
fnp-3388	1	119	published	publish	VERB
fnp-3388	1	120	:	:	PUNCT
fnp-3388	1	121	12	12	NUM
fnp-3388	1	122	july	july	PROPN
fnp-3388	1	123	2021	2021	NUM
fnp-3388	1	124	https://doi.org/10.17879/freeneuropathology-2021-3388	https://doi.org/10.17879/freeneuropathology-2021-3388	PROPN
fnp-3388	1	125	keywords	keyword	VERB
fnp-3388	1	126	:	:	PUNCT
fnp-3388	2	1	sars	sar	NOUN
fnp-3388	2	2	-	-	PUNCT
fnp-3388	2	3	cov-2	cov-2	NOUN
fnp-3388	2	4	,	,	PUNCT
fnp-3388	2	5	covid-19	covid-19	PROPN
fnp-3388	2	6	,	,	PUNCT
fnp-3388	2	7	acute	acute	NOUN
fnp-3388	2	8	disseminated	disseminate	VERB
fnp-3388	2	9	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	2	10	(	(	PUNCT
fnp-3388	2	11	adem	adem	PROPN
fnp-3388	2	12	)	)	PUNCT
fnp-3388	2	13	,	,	PUNCT
fnp-3388	2	14	acute	acute	ADJ
fnp-3388	2	15	hemorrhagic	hemorrhagic	NOUN
fnp-3388	2	16	leukoencephalitis	leukoencephalitis	ADJ
fnp-3388	2	17	(	(	PUNCT
fnp-3388	2	18	ahle	ahle	ADJ
fnp-3388	2	19	)	)	PUNCT
fnp-3388	2	20	,	,	PUNCT
fnp-3388	2	21	acute	acute	ADJ
fnp-3388	2	22	necrotizing	necrotizing	NOUN
fnp-3388	2	23	encephalopathy	encephalopathy	NOUN
fnp-3388	2	24	of	of	ADP
fnp-3388	2	25	childhood	childhood	NOUN
fnp-3388	2	26	(	(	PUNCT
fnp-3388	2	27	anec	anec	PROPN
fnp-3388	2	28	)	)	PUNCT
fnp-3388	2	29	,	,	PUNCT
fnp-3388	2	30	demyelinating	demyelinate	VERB
fnp-3388	2	31	abstract	abstract	ADJ
fnp-3388	2	32	cases	case	NOUN
fnp-3388	2	33	of	of	ADP
fnp-3388	2	34	acute	acute	NOUN
fnp-3388	2	35	disseminated	disseminate	VERB
fnp-3388	2	36	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	2	37	(	(	PUNCT
fnp-3388	2	38	adem	adem	PROPN
fnp-3388	2	39	)	)	PUNCT
fnp-3388	2	40	and	and	CCONJ
fnp-3388	2	41	its	its	PRON
fnp-3388	2	42	hyperacute	hyperacute	NOUN
fnp-3388	2	43	form	form	NOUN
fnp-3388	2	44	,	,	PUNCT
fnp-3388	2	45	acute	acute	ADJ
fnp-3388	2	46	hemorrhagic	hemorrhagic	NOUN
fnp-3388	2	47	leukoencephalitis	leukoencephalitis	ADJ
fnp-3388	2	48	(	(	PUNCT
fnp-3388	2	49	ahle	ahle	ADJ
fnp-3388	2	50	)	)	PUNCT
fnp-3388	2	51	,	,	PUNCT
fnp-3388	2	52	have	have	AUX
fnp-3388	2	53	been	be	AUX
fnp-3388	2	54	reported	report	VERB
fnp-3388	2	55	in	in	ADP
fnp-3388	2	56	coronavirus	coronavirus	NOUN
fnp-3388	2	57	disease	disease	NOUN
fnp-3388	2	58	2019	2019	NUM
fnp-3388	2	59	(	(	PUNCT
fnp-3388	2	60	covid-19	covid-19	PROPN
fnp-3388	2	61	)	)	PUNCT
fnp-3388	2	62	patients	patient	NOUN
fnp-3388	2	63	as	as	ADP
fnp-3388	2	64	rare	rare	ADJ
fnp-3388	2	65	,	,	PUNCT
fnp-3388	2	66	but	but	CCONJ
fnp-3388	2	67	most	most	ADJ
fnp-3388	2	68	severe	severe	ADJ
fnp-3388	2	69	neurological	neurological	ADJ
fnp-3388	2	70	complications	complication	NOUN
fnp-3388	2	71	.	.	PUNCT
fnp-3388	3	1	however	however	ADV
fnp-3388	3	2	,	,	PUNCT
fnp-3388	3	3	histopathologic	histopathologic	ADJ
fnp-3388	3	4	evaluations	evaluation	NOUN
fnp-3388	3	5	of	of	ADP
fnp-3388	3	6	adem	adem	PROPN
fnp-3388	3	7	/	/	SYM
fnp-3388	3	8	ahle	ahle	ADJ
fnp-3388	3	9	pathology	pathology	NOUN
fnp-3388	3	10	in	in	ADP
fnp-3388	3	11	covid	covid	PROPN
fnp-3388	3	12	patients	patient	NOUN
fnp-3388	3	13	are	be	AUX
fnp-3388	3	14	extremely	extremely	ADV
fnp-3388	3	15	limited	limited	ADJ
fnp-3388	3	16	,	,	PUNCT
fnp-3388	3	17	so	so	ADV
fnp-3388	3	18	far	far	ADV
fnp-3388	3	19	having	having	AUX
fnp-3388	3	20	only	only	ADV
fnp-3388	3	21	been	be	AUX
fnp-3388	3	22	reported	report	VERB
fnp-3388	3	23	in	in	ADP
fnp-3388	3	24	a	a	DET
fnp-3388	3	25	few	few	ADJ
fnp-3388	3	26	adult	adult	NOUN
fnp-3388	3	27	autopsy	autopsy	ADJ
fnp-3388	3	28	cases	case	NOUN
fnp-3388	3	29	.	.	PUNCT
fnp-3388	4	1	here	here	ADV
fnp-3388	4	2	we	we	PRON
fnp-3388	4	3	compare	compare	VERB
fnp-3388	4	4	the	the	DET
fnp-3388	4	5	findings	finding	NOUN
fnp-3388	4	6	with	with	ADP
fnp-3388	4	7	an	an	DET
fnp-3388	4	8	adem	adem	PROPN
fnp-3388	4	9	-	-	PUNCT
fnp-3388	4	10	like	like	ADJ
fnp-3388	4	11	pathology	pathology	NOUN
fnp-3388	4	12	in	in	ADP
fnp-3388	4	13	a	a	DET
fnp-3388	4	14	pediatric	pediatric	ADJ
fnp-3388	4	15	patient	patient	NOUN
fnp-3388	4	16	taken	take	VERB
fnp-3388	4	17	through	through	ADP
fnp-3388	4	18	a	a	DET
fnp-3388	4	19	biopsy	biopsy	NOUN
fnp-3388	4	20	procedure	procedure	NOUN
fnp-3388	4	21	.	.	PUNCT
fnp-3388	5	1	understanding	understand	VERB
fnp-3388	5	2	the	the	DET
fnp-3388	5	3	neuropathology	neuropathology	NOUN
fnp-3388	5	4	may	may	AUX
fnp-3388	5	5	shed	shed	VERB
fnp-3388	5	6	informative	informative	ADJ
fnp-3388	5	7	light	light	NOUN
fnp-3388	5	8	on	on	ADP
fnp-3388	5	9	the	the	DET
fnp-3388	5	10	autoimmune	autoimmune	ADJ
fnp-3388	5	11	process	process	NOUN
fnp-3388	5	12	affecting	affect	VERB
fnp-3388	5	13	covid-19	covid-19	PROPN
fnp-3388	5	14	patients	patient	NOUN
fnp-3388	5	15	and	and	CCONJ
fnp-3388	5	16	provide	provide	VERB
fnp-3388	5	17	critical	critical	ADJ
fnp-3388	5	18	information	information	NOUN
fnp-3388	5	19	to	to	PART
fnp-3388	5	20	guide	guide	VERB
fnp-3388	5	21	the	the	DET
fnp-3388	5	22	clinical	clinical	ADJ
fnp-3388	5	23	management	management	NOUN
fnp-3388	5	24	.	.	PUNCT
fnp-3388	6	1	numerous	numerous	ADJ
fnp-3388	6	2	evidence	evidence	NOUN
fnp-3388	6	3	has	have	AUX
fnp-3388	6	4	confirmed	confirm	VERB
fnp-3388	6	5	that	that	SCONJ
fnp-3388	6	6	coronavirus	coronavirus	NOUN
fnp-3388	6	7	disease	disease	NOUN
fnp-3388	6	8	2019	2019	NUM
fnp-3388	6	9	(	(	PUNCT
fnp-3388	6	10	covid-19	covid-19	PROPN
fnp-3388	6	11	)	)	PUNCT
fnp-3388	6	12	,	,	PUNCT
fnp-3388	6	13	caused	cause	VERB
fnp-3388	6	14	by	by	ADP
fnp-3388	6	15	severe	severe	ADJ
fnp-3388	6	16	acute	acute	ADJ
fnp-3388	6	17	respiratory	respiratory	ADJ
fnp-3388	6	18	syndrome	syndrome	NOUN
fnp-3388	6	19	coronavirus	coronavirus	NOUN
fnp-3388	6	20	2	2	NUM
fnp-3388	6	21	(	(	PUNCT
fnp-3388	6	22	sars	sar	NOUN
fnp-3388	6	23	-	-	PUNCT
fnp-3388	6	24	cov-2	cov-2	NOUN
fnp-3388	6	25	)	)	PUNCT
fnp-3388	7	1	[	[	X
fnp-3388	7	2	1	1	NUM
fnp-3388	7	3	]	]	PUNCT
fnp-3388	7	4	,	,	PUNCT
fnp-3388	7	5	affects	affect	VERB
fnp-3388	7	6	the	the	DET
fnp-3388	7	7	nervous	nervous	ADJ
fnp-3388	7	8	system	system	NOUN
fnp-3388	7	9	[	[	X
fnp-3388	7	10	2	2	NUM
fnp-3388	7	11	]	]	PUNCT
fnp-3388	7	12	.	.	PUNCT
fnp-3388	8	1	most	most	ADJ
fnp-3388	8	2	of	of	ADP
fnp-3388	8	3	the	the	DET
fnp-3388	8	4	associated	associated	ADJ
fnp-3388	8	5	neurological	neurological	ADJ
fnp-3388	8	6	dysfunctions	dysfunction	NOUN
fnp-3388	8	7	are	be	AUX
fnp-3388	8	8	mild	mild	ADJ
fnp-3388	8	9	symptoms	symptom	NOUN
fnp-3388	8	10	such	such	ADJ
fnp-3388	8	11	as	as	ADP
fnp-3388	8	12	anosmia	anosmia	NOUN
fnp-3388	8	13	and	and	CCONJ
fnp-3388	8	14	dysgeusia	dysgeusia	NOUN
fnp-3388	9	1	[	[	X
fnp-3388	9	2	3	3	X
fnp-3388	9	3	]	]	PUNCT
fnp-3388	9	4	while	while	SCONJ
fnp-3388	9	5	severe	severe	ADJ
fnp-3388	9	6	debilitating	debilitate	VERB
fnp-3388	9	7	neurological	neurological	ADJ
fnp-3388	9	8	disorders	disorder	NOUN
fnp-3388	9	9	such	such	ADJ
fnp-3388	9	10	as	as	ADP
fnp-3388	9	11	stroke	stroke	NOUN
fnp-3388	9	12	and	and	CCONJ
fnp-3388	9	13	meningoencephalitis	meningoencephalitis	NOUN
fnp-3388	9	14	are	be	AUX
fnp-3388	9	15	less	less	ADV
fnp-3388	9	16	frequent	frequent	ADJ
fnp-3388	10	1	[	[	X
fnp-3388	10	2	4	4	NUM
fnp-3388	10	3	,	,	PUNCT
fnp-3388	10	4	5	5	NUM
fnp-3388	10	5	]	]	PUNCT
fnp-3388	10	6	.	.	PUNCT
fnp-3388	11	1	these	these	DET
fnp-3388	11	2	manifestations	manifestation	NOUN
fnp-3388	11	3	are	be	AUX
fnp-3388	11	4	likely	likely	ADV
fnp-3388	11	5	caused	cause	VERB
fnp-3388	11	6	by	by	ADP
fnp-3388	11	7	sars	sar	NOUN
fnp-3388	11	8	-	-	PUNCT
fnp-3388	11	9	cov-2	cov-2	NOUN
fnp-3388	11	10	entering	enter	VERB
fnp-3388	11	11	brain	brain	NOUN
fnp-3388	11	12	through	through	ADP
fnp-3388	11	13	direct	direct	ADJ
fnp-3388	11	14	infection	infection	NOUN
fnp-3388	11	15	of	of	ADP
fnp-3388	11	16	olfactory	olfactory	ADJ
fnp-3388	11	17	neuroepithelium	neuroepithelium	NOUN
fnp-3388	12	1	[	[	X
fnp-3388	12	2	6	6	NUM
fnp-3388	12	3	]	]	PUNCT
fnp-3388	12	4	,	,	PUNCT
fnp-3388	12	5	or	or	CCONJ
fnp-3388	12	6	transmitted	transmit	VERB
fnp-3388	12	7	by	by	ADP
fnp-3388	12	8	circulating	circulate	VERB
fnp-3388	12	9	lymphocytes	lymphocyte	NOUN
fnp-3388	12	10	and	and	CCONJ
fnp-3388	12	11	monocytes	monocyte	NOUN
fnp-3388	12	12	that	that	PRON
fnp-3388	12	13	are	be	AUX
fnp-3388	12	14	able	able	ADJ
fnp-3388	12	15	to	to	PART
fnp-3388	12	16	cross	cross	VERB
fnp-3388	12	17	the	the	DET
fnp-3388	12	18	blood	blood	NOUN
fnp-3388	12	19	-	-	PUNCT
fnp-3388	12	20	brain	brain	NOUN
fnp-3388	12	21	barrier	barrier	NOUN
fnp-3388	12	22	[	[	X
fnp-3388	12	23	7	7	NUM
fnp-3388	12	24	]	]	PUNCT
fnp-3388	12	25	.	.	PUNCT
fnp-3388	13	1	within	within	ADP
fnp-3388	13	2	the	the	DET
fnp-3388	13	3	brain	brain	NOUN
fnp-3388	13	4	and	and	CCONJ
fnp-3388	13	5	spinal	spinal	ADJ
fnp-3388	13	6	cord	cord	NOUN
fnp-3388	13	7	,	,	PUNCT
fnp-3388	13	8	various	various	ADJ
fnp-3388	13	9	cell	cell	NOUN
fnp-3388	13	10	types	type	NOUN
fnp-3388	13	11	including	include	VERB
fnp-3388	13	12	endothelial	endothelial	ADJ
fnp-3388	13	13	cells	cell	NOUN
fnp-3388	13	14	,	,	PUNCT
fnp-3388	13	15	vascular	vascular	ADJ
fnp-3388	13	16	pericytes	pericyte	NOUN
fnp-3388	13	17	and	and	CCONJ
fnp-3388	13	18	smooth	smooth	ADJ
fnp-3388	13	19	muscle	muscle	NOUN
fnp-3388	13	20	,	,	PUNCT
fnp-3388	13	21	neurons	neuron	NOUN
fnp-3388	13	22	and	and	CCONJ
fnp-3388	13	23	glia	glia	NOUN
fnp-3388	13	24	all	all	PRON
fnp-3388	13	25	express	express	ADJ
fnp-3388	13	26	angiotensin	angiotensin	NOUN
fnp-3388	13	27	converting	convert	VERB
fnp-3388	13	28	enzyme	enzyme	NOUN
fnp-3388	13	29	2	2	NUM
fnp-3388	13	30	(	(	PUNCT
fnp-3388	13	31	ace2	ace2	NOUN
fnp-3388	13	32	)	)	PUNCT
fnp-3388	13	33	receptor	receptor	NOUN
fnp-3388	13	34	[	[	X
fnp-3388	13	35	8	8	NUM
fnp-3388	13	36	,	,	PUNCT
fnp-3388	13	37	9	9	NUM
fnp-3388	13	38	]	]	PUNCT
fnp-3388	13	39	,	,	PUNCT
fnp-3388	13	40	the	the	DET
fnp-3388	13	41	primary	primary	ADJ
fnp-3388	13	42	receptor	receptor	NOUN
fnp-3388	13	43	for	for	ADP
fnp-3388	13	44	sars	sar	NOUN
fnp-3388	13	45	-	-	PUNCT
fnp-3388	13	46	cov-2	cov-2	NOUN
fnp-3388	13	47	spike	spike	ADJ
fnp-3388	13	48	protein	protein	NOUN
fnp-3388	13	49	[	[	X
fnp-3388	13	50	10	10	NUM
fnp-3388	13	51	]	]	PUNCT
fnp-3388	13	52	.	.	PUNCT
fnp-3388	14	1	it	it	PRON
fnp-3388	14	2	is	be	AUX
fnp-3388	14	3	true	true	ADJ
fnp-3388	14	4	that	that	SCONJ
fnp-3388	14	5	sars	sar	NOUN
fnp-3388	14	6	-	-	PUNCT
fnp-3388	14	7	cov-2	cov-2	PART
fnp-3388	14	8	could	could	AUX
fnp-3388	14	9	be	be	AUX
fnp-3388	14	10	detected	detect	VERB
fnp-3388	14	11	in	in	ADP
fnp-3388	14	12	olfactory	olfactory	ADJ
fnp-3388	14	13	epithelium	epithelium	NOUN
fnp-3388	15	1	[	[	X
fnp-3388	15	2	11	11	NUM
fnp-3388	15	3	]	]	PUNCT
fnp-3388	15	4	,	,	PUNCT
fnp-3388	15	5	brain	brain	NOUN
fnp-3388	15	6	and	and	CCONJ
fnp-3388	15	7	cranial	cranial	ADJ
fnp-3388	15	8	nerves	nerve	NOUN
fnp-3388	15	9	by	by	ADP
fnp-3388	15	10	rt	rt	NOUN
fnp-3388	15	11	-	-	PUNCT
fnp-3388	15	12	pcr	pcr	PROPN
fnp-3388	15	13	[	[	X
fnp-3388	15	14	12	12	NUM
fnp-3388	15	15	,	,	PUNCT
fnp-3388	15	16	13	13	NUM
fnp-3388	15	17	]	]	PUNCT
fnp-3388	15	18	,	,	PUNCT
fnp-3388	15	19	immunohistochemistry	immunohistochemistry	PROPN
fnp-3388	15	20	(	(	PUNCT
fnp-3388	15	21	ihc	ihc	PROPN
fnp-3388	15	22	)	)	PUNCT
fnp-3388	16	1	[	[	X
fnp-3388	16	2	14	14	NUM
fnp-3388	16	3	]	]	X
fnp-3388	16	4	,	,	PUNCT
fnp-3388	16	5	in	in	ADP
fnp-3388	16	6	situ	situ	ADJ
fnp-3388	16	7	hybridization	hybridization	NOUN
fnp-3388	16	8	(	(	PUNCT
fnp-3388	16	9	ish	ish	PROPN
fnp-3388	16	10	)	)	PUNCT
fnp-3388	17	1	[	[	X
fnp-3388	17	2	11	11	NUM
fnp-3388	17	3	]	]	PUNCT
fnp-3388	17	4	and	and	CCONJ
fnp-3388	17	5	electron	electron	NOUN
fnp-3388	17	6	microscopy	microscopy	NOUN
fnp-3388	17	7	[	[	X
fnp-3388	17	8	15	15	NUM
fnp-3388	17	9	]	]	PUNCT
fnp-3388	17	10	.	.	PUNCT
fnp-3388	18	1	in	in	ADP
fnp-3388	18	2	addition	addition	NOUN
fnp-3388	18	3	,	,	PUNCT
fnp-3388	18	4	neuropathological	neuropathological	ADJ
fnp-3388	18	5	findings	finding	NOUN
fnp-3388	18	6	such	such	ADJ
fnp-3388	18	7	as	as	ADP
fnp-3388	18	8	leptomeningeal	leptomeningeal	ADJ
fnp-3388	18	9	and	and	CCONJ
fnp-3388	18	10	parenchymal	parenchymal	ADJ
fnp-3388	18	11	lymphocytic	lymphocytic	ADJ
fnp-3388	18	12	inflammation	inflammation	NOUN
fnp-3388	18	13	,	,	PUNCT
fnp-3388	18	14	microglial	microglial	ADJ
fnp-3388	18	15	nodules	nodule	NOUN
fnp-3388	18	16	and	and	CCONJ
fnp-3388	18	17	neuronophagy	neuronophagy	NOUN
fnp-3388	18	18	are	be	AUX
fnp-3388	18	19	compatible	compatible	ADJ
fnp-3388	18	20	with	with	ADP
fnp-3388	18	21	a	a	DET
fnp-3388	18	22	diagnosis	diagnosis	NOUN
fnp-3388	18	23	of	of	ADP
fnp-3388	18	24	viral	viral	ADJ
fnp-3388	18	25	meningoencephalitis	meningoencephalitis	NOUN
fnp-3388	19	1	[	[	X
fnp-3388	19	2	12	12	NUM
fnp-3388	19	3	,	,	PUNCT
fnp-3388	19	4	16	16	NUM
fnp-3388	19	5	]	]	PUNCT
fnp-3388	19	6	.	.	PUNCT
fnp-3388	20	1	nevertheless	nevertheless	ADV
fnp-3388	20	2	,	,	PUNCT
fnp-3388	20	3	neither	neither	PRON
fnp-3388	20	4	viral	viral	ADJ
fnp-3388	20	5	inclusions	inclusion	NOUN
fnp-3388	20	6	nor	nor	CCONJ
fnp-3388	20	7	cytopathic	cytopathic	ADJ
fnp-3388	20	8	changes	change	NOUN
fnp-3388	20	9	have	have	AUX
fnp-3388	20	10	been	be	AUX
fnp-3388	20	11	observed	observe	VERB
fnp-3388	20	12	on	on	ADP
fnp-3388	20	13	hematoxylin	hematoxylin	NOUN
fnp-3388	20	14	and	and	CCONJ
fnp-3388	20	15	eosin	eosin	PROPN
fnp-3388	20	16	(	(	PUNCT
fnp-3388	20	17	h&e	h&e	PROPN
fnp-3388	20	18	)	)	PUNCT
fnp-3388	20	19	stained	stain	VERB
fnp-3388	20	20	slides	slide	NOUN
fnp-3388	20	21	.	.	PUNCT
fnp-3388	21	1	furthermore	furthermore	ADV
fnp-3388	21	2	,	,	PUNCT
fnp-3388	21	3	in	in	ADP
fnp-3388	21	4	the	the	DET
fnp-3388	21	5	few	few	ADJ
fnp-3388	21	6	studies	study	NOUN
fnp-3388	21	7	that	that	PRON
fnp-3388	21	8	have	have	AUX
fnp-3388	21	9	reported	report	VERB
fnp-3388	21	10	evidence	evidence	NOUN
fnp-3388	21	11	of	of	ADP
fnp-3388	21	12	viral	viral	ADJ
fnp-3388	21	13	rna	rna	NOUN
fnp-3388	21	14	or	or	CCONJ
fnp-3388	21	15	protein	protein	NOUN
fnp-3388	21	16	in	in	ADP
fnp-3388	21	17	the	the	DET
fnp-3388	21	18	cranial	cranial	ADJ
fnp-3388	21	19	nerves	nerve	NOUN
fnp-3388	21	20	or	or	CCONJ
fnp-3388	21	21	brainstem	brainstem	NOUN
fnp-3388	21	22	,	,	PUNCT
fnp-3388	21	23	the	the	DET
fnp-3388	21	24	degree	degree	NOUN
fnp-3388	21	25	and	and	CCONJ
fnp-3388	21	26	distribution	distribution	NOUN
fnp-3388	21	27	of	of	ADP
fnp-3388	21	28	neuropathologic	neuropathologic	ADJ
fnp-3388	21	29	changes	change	NOUN
fnp-3388	21	30	have	have	AUX
fnp-3388	21	31	shown	show	VERB
fnp-3388	21	32	no	no	DET
fnp-3388	21	33	correlation	correlation	NOUN
fnp-3388	21	34	with	with	ADP
fnp-3388	21	35	the	the	DET
fnp-3388	21	36	amount	amount	NOUN
fnp-3388	21	37	of	of	ADP
fnp-3388	21	38	virus	virus	NOUN
fnp-3388	21	39	in	in	ADP
fnp-3388	21	40	a	a	DET
fnp-3388	21	41	given	give	VERB
fnp-3388	21	42	area	area	NOUN
fnp-3388	21	43	of	of	ADP
fnp-3388	21	44	pathology	pathology	NOUN
fnp-3388	21	45	,	,	PUNCT
fnp-3388	21	46	suggesting	suggest	VERB
fnp-3388	21	47	that	that	SCONJ
fnp-3388	21	48	the	the	DET
fnp-3388	21	49	pathology	pathology	NOUN
fnp-3388	21	50	is	be	AUX
fnp-3388	21	51	rather	rather	ADV
fnp-3388	21	52	secondary	secondary	ADJ
fnp-3388	21	53	to	to	ADP
fnp-3388	21	54	the	the	DET
fnp-3388	21	55	systemic	systemic	ADJ
fnp-3388	21	56	effects	effect	NOUN
fnp-3388	21	57	of	of	ADP
fnp-3388	21	58	viral	viral	ADJ
fnp-3388	21	59	infection	infection	NOUN
fnp-3388	21	60	.	.	PUNCT
fnp-3388	22	1	indeed	indeed	ADV
fnp-3388	22	2	,	,	PUNCT
fnp-3388	22	3	convincing	convince	VERB
fnp-3388	22	4	evidence	evidence	NOUN
fnp-3388	22	5	has	have	AUX
fnp-3388	22	6	elucidated	elucidate	VERB
fnp-3388	22	7	that	that	SCONJ
fnp-3388	22	8	systemic	systemic	ADJ
fnp-3388	22	9	hypercoagulability	hypercoagulability	NOUN
fnp-3388	22	10	plays	play	VERB
fnp-3388	22	11	an	an	DET
fnp-3388	22	12	important	important	ADJ
fnp-3388	22	13	role	role	NOUN
fnp-3388	22	14	in	in	ADP
fnp-3388	22	15	covid-19	covid-19	PROPN
fnp-3388	22	16	related	related	ADJ
fnp-3388	22	17	stroke	stroke	NOUN
fnp-3388	22	18	process	process	NOUN
fnp-3388	22	19	,	,	PUNCT
fnp-3388	22	20	as	as	SCONJ
fnp-3388	22	21	sars	sar	NOUN
fnp-3388	22	22	-	-	PUNCT
fnp-3388	22	23	cov-2	cov-2	NUM
fnp-3388	22	24	could	could	AUX
fnp-3388	22	25	induce	induce	VERB
fnp-3388	22	26	cytokine	cytokine	ADJ
fnp-3388	22	27	storm	storm	NOUN
fnp-3388	22	28	and	and	CCONJ
fnp-3388	22	29	endotheliopathy	endotheliopathy	ADJ
fnp-3388	22	30	[	[	X
fnp-3388	22	31	17	17	NUM
fnp-3388	22	32	,	,	PUNCT
fnp-3388	22	33	18	18	NUM
fnp-3388	22	34	]	]	PUNCT
fnp-3388	22	35	,	,	PUNCT
fnp-3388	22	36	which	which	PRON
fnp-3388	22	37	in	in	ADP
fnp-3388	22	38	turn	turn	NOUN
fnp-3388	22	39	lead	lead	VERB
fnp-3388	22	40	to	to	ADP
fnp-3388	22	41	the	the	DET
fnp-3388	22	42	histologic	histologic	ADJ
fnp-3388	22	43	findings	finding	NOUN
fnp-3388	22	44	of	of	ADP
fnp-3388	22	45	microthrombi	microthrombi	NOUN
fnp-3388	22	46	,	,	PUNCT
fnp-3388	22	47	hemorrhages	hemorrhage	NOUN
fnp-3388	22	48	and	and	CCONJ
fnp-3388	22	49	infarcts	infarct	VERB
fnp-3388	22	50	[	[	X
fnp-3388	22	51	19	19	NUM
fnp-3388	22	52	,	,	PUNCT
fnp-3388	22	53	20	20	NUM
fnp-3388	22	54	]	]	PUNCT
fnp-3388	22	55	.	.	PUNCT
fnp-3388	23	1	in	in	ADP
fnp-3388	23	2	contrast	contrast	NOUN
fnp-3388	23	3	,	,	PUNCT
fnp-3388	23	4	there	there	PRON
fnp-3388	23	5	is	be	VERB
fnp-3388	23	6	still	still	ADV
fnp-3388	23	7	considerable	considerable	ADJ
fnp-3388	23	8	debate	debate	NOUN
fnp-3388	23	9	over	over	ADP
fnp-3388	23	10	whether	whether	SCONJ
fnp-3388	23	11	parainfectious	parainfectious	ADJ
fnp-3388	23	12	,	,	PUNCT
fnp-3388	23	13	autoimmune	autoimmune	ADJ
fnp-3388	23	14	mediated	mediate	VERB
fnp-3388	23	15	process	process	NOUN
fnp-3388	23	16	such	such	ADJ
fnp-3388	23	17	as	as	ADP
fnp-3388	23	18	acute	acute	NOUN
fnp-3388	23	19	disseminated	disseminate	VERB
fnp-3388	23	20	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	23	21	(	(	PUNCT
fnp-3388	23	22	adem	adem	PROPN
fnp-3388	23	23	)	)	PUNCT
fnp-3388	23	24	,	,	PUNCT
fnp-3388	23	25	or	or	CCONJ
fnp-3388	23	26	its	its	PRON
fnp-3388	23	27	hyperacute	hyperacute	NOUN
fnp-3388	23	28	form	form	NOUN
fnp-3388	23	29	,	,	PUNCT
fnp-3388	23	30	acute	acute	ADJ
fnp-3388	23	31	hemorrhagic	hemorrhagic	NOUN
fnp-3388	23	32	leukoencephalopathy	leukoencephalopathy	ADV
fnp-3388	23	33	(	(	PUNCT
fnp-3388	23	34	ahle	ahle	ADJ
fnp-3388	23	35	)	)	PUNCT
fnp-3388	23	36	,	,	PUNCT
fnp-3388	23	37	can	can	AUX
fnp-3388	23	38	truly	truly	ADV
fnp-3388	23	39	be	be	AUX
fnp-3388	23	40	attributed	attribute	VERB
fnp-3388	23	41	to	to	ADP
fnp-3388	23	42	covid-19	covid-19	PROPN
fnp-3388	23	43	.	.	PUNCT
fnp-3388	24	1	one	one	NUM
fnp-3388	24	2	reason	reason	NOUN
fnp-3388	24	3	for	for	ADP
fnp-3388	24	4	this	this	DET
fnp-3388	24	5	controversy	controversy	NOUN
fnp-3388	24	6	is	be	AUX
fnp-3388	24	7	the	the	DET
fnp-3388	24	8	lack	lack	NOUN
fnp-3388	24	9	of	of	ADP
fnp-3388	24	10	neuropathological	neuropathological	ADJ
fnp-3388	24	11	descriptions	description	NOUN
fnp-3388	24	12	of	of	ADP
fnp-3388	24	13	adem	adem	PROPN
fnp-3388	24	14	and	and	CCONJ
fnp-3388	24	15	ahle	ahle	ADJ
fnp-3388	24	16	despite	despite	SCONJ
fnp-3388	24	17	that	that	PRON
fnp-3388	24	18	a	a	DET
fnp-3388	24	19	handful	handful	NOUN
fnp-3388	24	20	clinical	clinical	ADJ
fnp-3388	24	21	and	and	CCONJ
fnp-3388	24	22	imaging	imaging	NOUN
fnp-3388	24	23	case	case	NOUN
fnp-3388	24	24	studies	study	NOUN
fnp-3388	24	25	of	of	ADP
fnp-3388	24	26	covid-19	covid-19	PROPN
fnp-3388	24	27	patients	patient	NOUN
fnp-3388	24	28	have	have	AUX
fnp-3388	24	29	suggested	suggest	VERB
fnp-3388	24	30	lesions	lesion	NOUN
fnp-3388	24	31	characteristic	characteristic	ADJ
fnp-3388	24	32	of	of	ADP
fnp-3388	24	33	adem	adem	PROPN
fnp-3388	24	34	or	or	CCONJ
fnp-3388	24	35	ahle	ahle	ADJ
fnp-3388	24	36	[	[	X
fnp-3388	24	37	21	21	NUM
fnp-3388	24	38	-	-	SYM
fnp-3388	24	39	31	31	NUM
fnp-3388	24	40	]	]	PUNCT
fnp-3388	24	41	.	.	PUNCT
fnp-3388	25	1	so	so	ADV
fnp-3388	25	2	far	far	ADV
fnp-3388	25	3	,	,	PUNCT
fnp-3388	25	4	there	there	PRON
fnp-3388	25	5	are	be	VERB
fnp-3388	25	6	only	only	ADV
fnp-3388	25	7	few	few	ADJ
fnp-3388	25	8	case	case	NOUN
fnp-3388	25	9	reports	report	NOUN
fnp-3388	25	10	with	with	ADP
fnp-3388	25	11	neuropathological	neuropathological	ADJ
fnp-3388	25	12	features	feature	NOUN
fnp-3388	25	13	of	of	ADP
fnp-3388	25	14	adem	adem	PROPN
fnp-3388	25	15	and	and	CCONJ
fnp-3388	25	16	ahle	ahle	ADJ
fnp-3388	25	17	in	in	ADP
fnp-3388	25	18	adult	adult	NOUN
fnp-3388	25	19	patients	patient	NOUN
fnp-3388	25	20	who	who	PRON
fnp-3388	25	21	died	die	VERB
fnp-3388	25	22	from	from	ADP
fnp-3388	25	23	complications	complication	NOUN
fnp-3388	25	24	of	of	ADP
fnp-3388	25	25	covid-19	covid-19	PROPN
fnp-3388	26	1	[	[	X
fnp-3388	26	2	32	32	NUM
fnp-3388	26	3	-	-	SYM
fnp-3388	26	4	34	34	NUM
fnp-3388	26	5	]	]	PUNCT
fnp-3388	26	6	.	.	PUNCT
fnp-3388	27	1	another	another	DET
fnp-3388	27	2	reason	reason	NOUN
fnp-3388	27	3	for	for	ADP
fnp-3388	27	4	the	the	DET
fnp-3388	27	5	controversy	controversy	NOUN
fnp-3388	27	6	,	,	PUNCT
fnp-3388	27	7	as	as	SCONJ
fnp-3388	27	8	will	will	AUX
fnp-3388	27	9	be	be	AUX
fnp-3388	27	10	discussed	discuss	VERB
fnp-3388	27	11	further	far	ADV
fnp-3388	27	12	below	below	ADV
fnp-3388	27	13	,	,	PUNCT
fnp-3388	27	14	is	be	AUX
fnp-3388	27	15	whether	whether	SCONJ
fnp-3388	27	16	the	the	DET
fnp-3388	27	17	observed	observed	ADJ
fnp-3388	27	18	ademor	ademor	NOUN
fnp-3388	27	19	ahle	ahle	ADJ
fnp-3388	27	20	-	-	PUNCT
fnp-3388	27	21	like	like	ADJ
fnp-3388	27	22	pathology	pathology	NOUN
fnp-3388	27	23	is	be	AUX
fnp-3388	27	24	truly	truly	ADV
fnp-3388	27	25	due	due	ADJ
fnp-3388	27	26	to	to	ADP
fnp-3388	27	27	a	a	DET
fnp-3388	27	28	primary	primary	ADJ
fnp-3388	27	29	demyelinating	demyelinate	VERB
fnp-3388	27	30	process	process	NOUN
fnp-3388	27	31	or	or	CCONJ
fnp-3388	27	32	merely	merely	ADV
fnp-3388	27	33	a	a	DET
fnp-3388	27	34	secondary	secondary	ADJ
fnp-3388	27	35	white	white	ADJ
fnp-3388	27	36	matter	matter	NOUN
fnp-3388	27	37	injury	injury	NOUN
fnp-3388	27	38	of	of	ADP
fnp-3388	27	39	a	a	DET
fnp-3388	27	40	comorbid	comorbid	NOUN
fnp-3388	27	41	vascular	vascular	ADJ
fnp-3388	27	42	disease	disease	NOUN
fnp-3388	27	43	or	or	CCONJ
fnp-3388	27	44	a	a	DET
fnp-3388	27	45	combination	combination	NOUN
fnp-3388	27	46	.	.	PUNCT
fnp-3388	28	1	r.	r.	PROPN
fnp-3388	28	2	ross	ross	PROPN
fnp-3388	28	3	reichard	reichard	PROPN
fnp-3388	28	4	et	et	PROPN
fnp-3388	28	5	al	al	PROPN
fnp-3388	28	6	.	.	PROPN
fnp-3388	28	7	reported	report	VERB
fnp-3388	28	8	the	the	DET
fnp-3388	28	9	neuropathological	neuropathological	ADJ
fnp-3388	28	10	findings	finding	NOUN
fnp-3388	28	11	of	of	ADP
fnp-3388	28	12	a	a	DET
fnp-3388	28	13	71	71	NUM
fnp-3388	28	14	-	-	PUNCT
fnp-3388	28	15	year	year	NOUN
fnp-3388	28	16	-	-	PUNCT
fnp-3388	28	17	old	old	ADJ
fnp-3388	28	18	patient	patient	NOUN
fnp-3388	28	19	who	who	PRON
fnp-3388	28	20	died	die	VERB
fnp-3388	28	21	from	from	ADP
fnp-3388	28	22	complications	complication	NOUN
fnp-3388	28	23	of	of	ADP
fnp-3388	28	24	covid-19	covid-19	PROPN
fnp-3388	29	1	[	[	X
fnp-3388	29	2	32	32	NUM
fnp-3388	29	3	]	]	PUNCT
fnp-3388	29	4	.	.	PUNCT
fnp-3388	30	1	hemorrhagic	hemorrhagic	PROPN
fnp-3388	30	2	white	white	ADJ
fnp-3388	30	3	matter	matter	NOUN
fnp-3388	30	4	lesions	lesion	NOUN
fnp-3388	30	5	were	be	AUX
fnp-3388	30	6	present	present	ADJ
fnp-3388	30	7	throughout	throughout	ADP
fnp-3388	30	8	the	the	DET
fnp-3388	30	9	cerebral	cerebral	ADJ
fnp-3388	30	10	hemispheres	hemisphere	NOUN
fnp-3388	30	11	.	.	PUNCT
fnp-3388	31	1	luxol	luxol	NOUN
fnp-3388	31	2	fast	fast	VERB
fnp-3388	31	3	blue/	blue/	NUM
fnp-3388	31	4	periodic	periodic	ADJ
fnp-3388	31	5	acid	acid	NOUN
fnp-3388	31	6	–	–	PUNCT
fnp-3388	31	7	schiff	schiff	NOUN
fnp-3388	31	8	(	(	PUNCT
fnp-3388	31	9	lfb	lfb	PROPN
fnp-3388	31	10	/	/	SYM
fnp-3388	31	11	pas	pas	PROPN
fnp-3388	31	12	)	)	PUNCT
fnp-3388	31	13	identified	identify	VERB
fnp-3388	31	14	loss	loss	NOUN
fnp-3388	31	15	of	of	ADP
fnp-3388	31	16	myelin	myelin	NOUN
fnp-3388	31	17	,	,	PUNCT
fnp-3388	31	18	pas	pas	NOUN
fnp-3388	31	19	-	-	PUNCT
fnp-3388	31	20	positive	positive	ADJ
fnp-3388	31	21	macrophages	macrophage	NOUN
fnp-3388	31	22	,	,	PUNCT
fnp-3388	31	23	and	and	CCONJ
fnp-3388	31	24	fragmented	fragmented	ADJ
fnp-3388	31	25	axonal	axonal	ADJ
fnp-3388	31	26	processes	process	NOUN
fnp-3388	31	27	within	within	ADP
fnp-3388	31	28	these	these	DET
fnp-3388	31	29	lesions	lesion	NOUN
fnp-3388	31	30	.	.	PUNCT
fnp-3388	32	1	it	it	PRON
fnp-3388	32	2	has	have	VERB
fnp-3388	32	3	features	feature	NOUN
fnp-3388	32	4	of	of	ADP
fnp-3388	32	5	ahle	ahle	ADJ
fnp-3388	32	6	,	,	PUNCT
fnp-3388	32	7	although	although	SCONJ
fnp-3388	32	8	necrotic	necrotic	ADJ
fnp-3388	32	9	blood	blood	NOUN
fnp-3388	32	10	vessels	vessel	NOUN
fnp-3388	32	11	and	and	CCONJ
fnp-3388	32	12	perivascular	perivascular	ADJ
fnp-3388	32	13	inflammation	inflammation	NOUN
fnp-3388	32	14	were	be	AUX
fnp-3388	32	15	not	not	PART
fnp-3388	32	16	identified	identify	VERB
fnp-3388	32	17	within	within	ADP
fnp-3388	32	18	the	the	DET
fnp-3388	32	19	hemorrhagic	hemorrhagic	NOUN
fnp-3388	32	20	lesions	lesion	NOUN
fnp-3388	32	21	.	.	PUNCT
fnp-3388	33	1	a	a	DET
fnp-3388	33	2	second	second	ADJ
fnp-3388	33	3	distinct	distinct	ADJ
fnp-3388	33	4	pathology	pathology	NOUN
fnp-3388	33	5	identified	identify	VERB
fnp-3388	33	6	was	be	AUX
fnp-3388	33	7	characterized	characterize	VERB
fnp-3388	33	8	by	by	ADP
fnp-3388	33	9	small	small	ADJ
fnp-3388	33	10	subcortical	subcortical	ADJ
fnp-3388	33	11	white	white	ADJ
fnp-3388	33	12	matter	matter	NOUN
fnp-3388	33	13	pallor	pallor	NOUN
fnp-3388	33	14	with	with	ADP
fnp-3388	33	15	a	a	DET
fnp-3388	33	16	variable	variable	ADJ
fnp-3388	33	17	perivenular	perivenular	ADJ
fnp-3388	33	18	distribution	distribution	NOUN
fnp-3388	33	19	,	,	PUNCT
fnp-3388	33	20	resembling	resemble	VERB
fnp-3388	33	21	an	an	DET
fnp-3388	33	22	adem	adem	PROPN
fnp-3388	33	23	-	-	PUNCT
fnp-3388	33	24	like	like	ADJ
fnp-3388	33	25	histological	histological	ADJ
fnp-3388	33	26	appearance	appearance	NOUN
fnp-3388	33	27	.	.	PUNCT
fnp-3388	34	1	notably	notably	ADV
fnp-3388	34	2	,	,	PUNCT
fnp-3388	34	3	prominent	prominent	ADJ
fnp-3388	34	4	acute	acute	ADJ
fnp-3388	34	5	axonal	axonal	ADJ
fnp-3388	34	6	injury	injury	NOUN
fnp-3388	34	7	was	be	AUX
fnp-3388	34	8	present	present	ADJ
fnp-3388	34	9	in	in	ADP
fnp-3388	34	10	the	the	DET
fnp-3388	34	11	regions	region	NOUN
fnp-3388	34	12	of	of	ADP
fnp-3388	34	13	myelin	myelin	ADJ
fnp-3388	34	14	loss	loss	NOUN
fnp-3388	34	15	,	,	PUNCT
fnp-3388	34	16	which	which	PRON
fnp-3388	34	17	is	be	AUX
fnp-3388	34	18	not	not	PART
fnp-3388	34	19	characteristic	characteristic	ADJ
fnp-3388	34	20	of	of	ADP
fnp-3388	34	21	classic	classic	ADJ
fnp-3388	34	22	adem	adem	PROPN
fnp-3388	35	1	[	[	X
fnp-3388	35	2	32	32	NUM
fnp-3388	35	3	]	]	PUNCT
fnp-3388	35	4	.	.	PUNCT
fnp-3388	36	1	jamie	jamie	PROPN
fnp-3388	36	2	m.	m.	PROPN
fnp-3388	36	3	walker	walker	PROPN
fnp-3388	36	4	et	et	PROPN
fnp-3388	36	5	al	al	PROPN
fnp-3388	36	6	.	.	PROPN
fnp-3388	36	7	presented	present	VERB
fnp-3388	36	8	two	two	NUM
fnp-3388	36	9	cases	case	NOUN
fnp-3388	36	10	of	of	ADP
fnp-3388	36	11	fatal	fatal	ADJ
fnp-3388	36	12	covid-19	covid-19	PROPN
fnp-3388	36	13	with	with	ADP
fnp-3388	36	14	severe	severe	ADJ
fnp-3388	36	15	neurologic	neurologic	ADJ
fnp-3388	36	16	sequalae	sequalae	NOUN
fnp-3388	36	17	[	[	X
fnp-3388	36	18	33	33	NUM
fnp-3388	36	19	]	]	PUNCT
fnp-3388	36	20	.	.	PUNCT
fnp-3388	37	1	one	one	NUM
fnp-3388	37	2	was	be	AUX
fnp-3388	37	3	a	a	DET
fnp-3388	37	4	51	51	NUM
fnp-3388	37	5	-	-	PUNCT
fnp-3388	37	6	year	year	NOUN
fnp-3388	37	7	-	-	PUNCT
fnp-3388	37	8	old	old	ADJ
fnp-3388	37	9	woman	woman	NOUN
fnp-3388	37	10	with	with	ADP
fnp-3388	37	11	an	an	DET
fnp-3388	37	12	irregular	irregular	ADJ
fnp-3388	37	13	pattern	pattern	NOUN
fnp-3388	37	14	of	of	ADP
fnp-3388	37	15	demyelination	demyelination	NOUN
fnp-3388	37	16	centered	center	VERB
fnp-3388	37	17	primarily	primarily	ADV
fnp-3388	37	18	around	around	ADP
fnp-3388	37	19	veins	vein	NOUN
fnp-3388	37	20	and	and	CCONJ
fnp-3388	37	21	venules	venule	NOUN
fnp-3388	37	22	.	.	PUNCT
fnp-3388	38	1	both	both	PRON
fnp-3388	38	2	perivascular	perivascular	ADJ
fnp-3388	38	3	cd3	cd3	PROPN
fnp-3388	38	4	+	+	PROPN
fnp-3388	38	5	t	t	NOUN
fnp-3388	38	6	-	-	PUNCT
fnp-3388	38	7	lymphocytes	lymphocyte	NOUN
fnp-3388	38	8	as	as	ADV
fnp-3388	38	9	well	well	ADV
fnp-3388	38	10	as	as	ADP
fnp-3388	38	11	frequent	frequent	ADJ
fnp-3388	38	12	perivascular	perivascular	ADJ
fnp-3388	38	13	and	and	CCONJ
fnp-3388	38	14	parenchymal	parenchymal	ADJ
fnp-3388	38	15	cd68	cd68	PROPN
fnp-3388	38	16	+	+	NUM
fnp-3388	38	17	histiocytes	histiocyte	NOUN
fnp-3388	38	18	and	and	CCONJ
fnp-3388	38	19	activated	activate	VERB
fnp-3388	38	20	microglial	microglial	ADJ
fnp-3388	38	21	cells	cell	NOUN
fnp-3388	38	22	were	be	AUX
fnp-3388	38	23	present	present	ADJ
fnp-3388	38	24	,	,	PUNCT
fnp-3388	38	25	consistent	consistent	ADJ
fnp-3388	38	26	with	with	ADP
fnp-3388	38	27	a	a	DET
fnp-3388	38	28	diagnosis	diagnosis	NOUN
fnp-3388	38	29	of	of	ADP
fnp-3388	38	30	adem	adem	PROPN
fnp-3388	38	31	.	.	PUNCT
fnp-3388	39	1	another	another	DET
fnp-3388	39	2	autopsy	autopsy	ADJ
fnp-3388	39	3	examination	examination	NOUN
fnp-3388	39	4	of	of	ADP
fnp-3388	39	5	a	a	DET
fnp-3388	39	6	64	64	NUM
fnp-3388	39	7	-	-	PUNCT
fnp-3388	39	8	year	year	NOUN
fnp-3388	39	9	-	-	PUNCT
fnp-3388	39	10	old	old	ADJ
fnp-3388	39	11	demonstrated	demonstrate	VERB
fnp-3388	39	12	myelin	myelin	ADJ
fnp-3388	39	13	pallor	pallor	NOUN
fnp-3388	39	14	,	,	PUNCT
fnp-3388	39	15	perivascular	perivascular	PROPN
fnp-3388	39	16	cd3	cd3	PROPN
fnp-3388	39	17	+	+	PROPN
fnp-3388	39	18	t	t	NOUN
fnp-3388	39	19	-	-	PUNCT
fnp-3388	39	20	lymphocytes	lymphocyte	NOUN
fnp-3388	39	21	,	,	PUNCT
fnp-3388	39	22	axonal	axonal	ADJ
fnp-3388	39	23	spheroids	spheroid	NOUN
fnp-3388	39	24	,	,	PUNCT
fnp-3388	39	25	as	as	ADV
fnp-3388	39	26	well	well	ADV
fnp-3388	39	27	as	as	ADP
fnp-3388	39	28	numerous	numerous	ADJ
fnp-3388	39	29	ringand	ringand	NOUN
fnp-3388	39	30	ball	ball	NOUN
fnp-3388	39	31	-	-	PUNCT
fnp-3388	39	32	hemorrhages	hemorrhage	NOUN
fnp-3388	39	33	throughout	throughout	ADP
fnp-3388	39	34	the	the	DET
fnp-3388	39	35	white	white	ADJ
fnp-3388	39	36	matter	matter	NOUN
fnp-3388	39	37	with	with	ADP
fnp-3388	39	38	central	central	ADJ
fnp-3388	39	39	blood	blood	NOUN
fnp-3388	39	40	vessels	vessel	NOUN
fnp-3388	39	41	showing	show	VERB
fnp-3388	39	42	fibrinoid	fibrinoid	ADJ
fnp-3388	39	43	necrosis	necrosis	NOUN
fnp-3388	39	44	,	,	PUNCT
fnp-3388	39	45	most	most	ADV
fnp-3388	39	46	consistent	consistent	ADJ
fnp-3388	39	47	with	with	ADP
fnp-3388	39	48	a	a	DET
fnp-3388	39	49	diagnosis	diagnosis	NOUN
fnp-3388	39	50	of	of	ADP
fnp-3388	39	51	ahle	ahle	ADJ
fnp-3388	39	52	.	.	PUNCT
fnp-3388	40	1	it	it	PRON
fnp-3388	40	2	should	should	AUX
fnp-3388	40	3	be	be	AUX
fnp-3388	40	4	noted	note	VERB
fnp-3388	40	5	that	that	SCONJ
fnp-3388	40	6	in	in	ADP
fnp-3388	40	7	all	all	DET
fnp-3388	40	8	three	three	NUM
fnp-3388	40	9	aforementioned	aforementioned	ADJ
fnp-3388	40	10	cases	case	NOUN
fnp-3388	40	11	,	,	PUNCT
fnp-3388	40	12	global	global	ADJ
fnp-3388	40	13	hypoxic	hypoxic	ADJ
fnp-3388	40	14	-	-	PUNCT
fnp-3388	40	15	ischemic	ischemic	ADJ
fnp-3388	40	16	injury	injury	NOUN
fnp-3388	40	17	was	be	AUX
fnp-3388	40	18	present	present	ADJ
fnp-3388	40	19	,	,	PUNCT
fnp-3388	40	20	in	in	ADP
fnp-3388	40	21	addition	addition	NOUN
fnp-3388	40	22	to	to	ADP
fnp-3388	40	23	microscopic	microscopic	ADJ
fnp-3388	40	24	cortical	cortical	ADJ
fnp-3388	40	25	infarcts	infarct	NOUN
fnp-3388	40	26	in	in	ADP
fnp-3388	40	27	the	the	DET
fnp-3388	40	28	first	first	ADJ
fnp-3388	40	29	case	case	NOUN
fnp-3388	41	1	[	[	X
fnp-3388	41	2	32	32	NUM
fnp-3388	41	3	]	]	PUNCT
fnp-3388	41	4	and	and	CCONJ
fnp-3388	41	5	large	large	ADJ
fnp-3388	41	6	areas	area	NOUN
fnp-3388	41	7	of	of	ADP
fnp-3388	41	8	cerebral	cerebral	ADJ
fnp-3388	41	9	intraparenchymal	intraparenchymal	ADJ
fnp-3388	41	10	hemorrhages	hemorrhage	NOUN
fnp-3388	41	11	in	in	ADP
fnp-3388	41	12	the	the	DET
fnp-3388	41	13	third	third	ADJ
fnp-3388	41	14	case	case	NOUN
fnp-3388	42	1	[	[	X
fnp-3388	42	2	33	33	NUM
fnp-3388	42	3	]	]	PUNCT
fnp-3388	42	4	.	.	PUNCT
fnp-3388	43	1	thus	thus	ADV
fnp-3388	43	2	,	,	PUNCT
fnp-3388	43	3	the	the	DET
fnp-3388	43	4	neuropathological	neuropathological	ADJ
fnp-3388	43	5	lesions	lesion	NOUN
fnp-3388	43	6	should	should	AUX
fnp-3388	43	7	be	be	AUX
fnp-3388	43	8	interpreted	interpret	VERB
fnp-3388	43	9	with	with	ADP
fnp-3388	43	10	caution	caution	NOUN
fnp-3388	43	11	and	and	CCONJ
fnp-3388	43	12	the	the	DET
fnp-3388	43	13	possibility	possibility	NOUN
fnp-3388	43	14	of	of	ADP
fnp-3388	43	15	a	a	DET
fnp-3388	43	16	cerebrovascular	cerebrovascular	ADJ
fnp-3388	43	17	origin	origin	NOUN
fnp-3388	43	18	with	with	ADP
fnp-3388	43	19	secondary	secondary	ADJ
fnp-3388	43	20	demyelinating	demyelinate	VERB
fnp-3388	43	21	pathology	pathology	NOUN
fnp-3388	43	22	should	should	AUX
fnp-3388	43	23	be	be	AUX
fnp-3388	43	24	considered	consider	VERB
fnp-3388	43	25	.	.	PUNCT
fnp-3388	44	1	adem	adem	PROPN
fnp-3388	44	2	and	and	CCONJ
fnp-3388	44	3	ahle	ahle	ADJ
fnp-3388	44	4	usually	usually	ADV
fnp-3388	44	5	affects	affect	VERB
fnp-3388	44	6	children	child	NOUN
fnp-3388	44	7	and	and	CCONJ
fnp-3388	44	8	young	young	ADJ
fnp-3388	44	9	adults	adult	NOUN
fnp-3388	44	10	after	after	ADP
fnp-3388	44	11	an	an	DET
fnp-3388	44	12	infection	infection	NOUN
fnp-3388	44	13	or	or	CCONJ
fnp-3388	44	14	vaccination	vaccination	NOUN
fnp-3388	44	15	[	[	X
fnp-3388	44	16	35	35	NUM
fnp-3388	44	17	]	]	PUNCT
fnp-3388	44	18	.	.	PUNCT
fnp-3388	45	1	however	however	ADV
fnp-3388	45	2	there	there	PRON
fnp-3388	45	3	are	be	VERB
fnp-3388	45	4	very	very	ADV
fnp-3388	45	5	few	few	ADJ
fnp-3388	45	6	reported	report	VERB
fnp-3388	45	7	cases	case	NOUN
fnp-3388	45	8	of	of	ADP
fnp-3388	45	9	adem	adem	PROPN
fnp-3388	45	10	in	in	ADP
fnp-3388	45	11	pediatric	pediatric	ADJ
fnp-3388	45	12	population	population	NOUN
fnp-3388	45	13	with	with	ADP
fnp-3388	45	14	sars	sar	NOUN
fnp-3388	45	15	-	-	PUNCT
fnp-3388	45	16	cov-2	cov-2	PART
fnp-3388	45	17	infection	infection	NOUN
fnp-3388	45	18	based	base	VERB
fnp-3388	45	19	on	on	ADP
fnp-3388	45	20	clinical	clinical	ADJ
fnp-3388	45	21	features	feature	NOUN
fnp-3388	45	22	and	and	CCONJ
fnp-3388	45	23	mri	mri	NOUN
fnp-3388	45	24	findings	finding	NOUN
fnp-3388	45	25	[	[	X
fnp-3388	45	26	25	25	NUM
fnp-3388	45	27	,	,	PUNCT
fnp-3388	45	28	36	36	NUM
fnp-3388	45	29	,	,	PUNCT
fnp-3388	45	30	37	37	NUM
fnp-3388	45	31	]	]	PUNCT
fnp-3388	45	32	.	.	PUNCT
fnp-3388	46	1	this	this	PRON
fnp-3388	46	2	is	be	AUX
fnp-3388	46	3	consistent	consistent	ADJ
fnp-3388	46	4	with	with	ADP
fnp-3388	46	5	the	the	DET
fnp-3388	46	6	differing	differ	VERB
fnp-3388	46	7	clinical	clinical	ADJ
fnp-3388	46	8	presentations	presentation	NOUN
fnp-3388	46	9	of	of	ADP
fnp-3388	46	10	covid-19	covid-19	PROPN
fnp-3388	46	11	in	in	ADP
fnp-3388	46	12	children	child	NOUN
fnp-3388	46	13	and	and	CCONJ
fnp-3388	46	14	adult	adult	NOUN
fnp-3388	46	15	patients	patient	NOUN
fnp-3388	46	16	.	.	PUNCT
fnp-3388	47	1	recently	recently	ADV
fnp-3388	47	2	,	,	PUNCT
fnp-3388	47	3	we	we	PRON
fnp-3388	47	4	have	have	AUX
fnp-3388	47	5	examined	examine	VERB
fnp-3388	47	6	a	a	DET
fnp-3388	47	7	brain	brain	NOUN
fnp-3388	47	8	biopsy	biopsy	NOUN
fnp-3388	47	9	taken	take	VERB
fnp-3388	47	10	from	from	ADP
fnp-3388	47	11	an	an	DET
fnp-3388	47	12	8	8	NUM
fnp-3388	47	13	-	-	PUNCT
fnp-3388	47	14	year	year	NOUN
fnp-3388	47	15	-	-	PUNCT
fnp-3388	47	16	old	old	ADJ
fnp-3388	47	17	girl	girl	NOUN
fnp-3388	47	18	who	who	PRON
fnp-3388	47	19	was	be	AUX
fnp-3388	47	20	admitted	admit	VERB
fnp-3388	47	21	with	with	ADP
fnp-3388	47	22	new	new	ADJ
fnp-3388	47	23	-	-	PUNCT
fnp-3388	47	24	onset	onset	NOUN
fnp-3388	47	25	seizures	seizure	NOUN
fnp-3388	47	26	.	.	PUNCT
fnp-3388	48	1	on	on	ADP
fnp-3388	48	2	hospital	hospital	NOUN
fnp-3388	48	3	day	day	NOUN
fnp-3388	48	4	2	2	NUM
fnp-3388	48	5	,	,	PUNCT
fnp-3388	48	6	covid-19	covid-19	PROPN
fnp-3388	48	7	spike	spike	ADJ
fnp-3388	48	8	igg	igg	NOUN
fnp-3388	48	9	antibody	antibody	NOUN
fnp-3388	48	10	testing	testing	NOUN
fnp-3388	48	11	was	be	AUX
fnp-3388	48	12	positive	positive	ADJ
fnp-3388	48	13	.	.	PUNCT
fnp-3388	49	1	brain	brain	NOUN
fnp-3388	49	2	mri	mri	NOUN
fnp-3388	49	3	demonstrated	demonstrate	VERB
fnp-3388	49	4	extensive	extensive	ADJ
fnp-3388	49	5	t2	t2	NOUN
fnp-3388	49	6	hyperintensity	hyperintensity	NOUN
fnp-3388	49	7	centered	center	VERB
fnp-3388	49	8	at	at	ADP
fnp-3388	49	9	bilateral	bilateral	ADJ
fnp-3388	49	10	basal	basal	ADJ
fnp-3388	49	11	ganglia	ganglia	NOUN
fnp-3388	49	12	,	,	PUNCT
fnp-3388	49	13	extending	extend	VERB
fnp-3388	49	14	to	to	ADP
fnp-3388	49	15	the	the	DET
fnp-3388	49	16	frontal	frontal	ADJ
fnp-3388	49	17	white	white	ADJ
fnp-3388	49	18	matter	matter	NOUN
fnp-3388	49	19	,	,	PUNCT
fnp-3388	49	20	external	external	ADJ
fnp-3388	49	21	and	and	CCONJ
fnp-3388	49	22	internal	internal	ADJ
fnp-3388	49	23	capsules	capsule	NOUN
fnp-3388	49	24	,	,	PUNCT
fnp-3388	49	25	corpus	corpus	NOUN
fnp-3388	49	26	callosum	callosum	NOUN
fnp-3388	49	27	,	,	PUNCT
fnp-3388	49	28	thalami	thalami	NOUN
fnp-3388	49	29	,	,	PUNCT
fnp-3388	49	30	insula	insula	NOUN
fnp-3388	49	31	,	,	PUNCT
fnp-3388	49	32	as	as	ADV
fnp-3388	49	33	well	well	ADV
fnp-3388	49	34	as	as	ADP
fnp-3388	49	35	the	the	DET
fnp-3388	49	36	cerebellar	cerebellar	ADJ
fnp-3388	49	37	hemispheres	hemisphere	NOUN
fnp-3388	49	38	,	,	PUNCT
fnp-3388	49	39	brainstem	brainstem	NOUN
fnp-3388	49	40	and	and	CCONJ
fnp-3388	49	41	the	the	DET
fnp-3388	49	42	spinal	spinal	NOUN
fnp-3388	49	43	cord	cord	NOUN
fnp-3388	49	44	.	.	PUNCT
fnp-3388	50	1	interval	interval	NOUN
fnp-3388	50	2	mri	mri	NOUN
fnp-3388	50	3	imaging	imaging	NOUN
fnp-3388	50	4	demonstrated	demonstrate	VERB
fnp-3388	50	5	persistent	persistent	ADJ
fnp-3388	50	6	diffusion	diffusion	NOUN
fnp-3388	50	7	restriction	restriction	NOUN
fnp-3388	50	8	in	in	ADP
fnp-3388	50	9	the	the	DET
fnp-3388	50	10	affected	affect	VERB
fnp-3388	50	11	white	white	ADJ
fnp-3388	50	12	matter	matter	NOUN
fnp-3388	50	13	throughout	throughout	ADP
fnp-3388	50	14	much	much	ADJ
fnp-3388	50	15	of	of	ADP
fnp-3388	50	16	the	the	DET
fnp-3388	50	17	central	central	ADJ
fnp-3388	50	18	white	white	ADJ
fnp-3388	50	19	matter	matter	NOUN
fnp-3388	50	20	tracts	tract	NOUN
fnp-3388	50	21	,	,	PUNCT
fnp-3388	50	22	cerebral	cerebral	ADJ
fnp-3388	50	23	peduncles	peduncle	NOUN
fnp-3388	50	24	,	,	PUNCT
fnp-3388	50	25	corticospinal	corticospinal	ADJ
fnp-3388	50	26	tracts	tract	NOUN
fnp-3388	50	27	and	and	CCONJ
fnp-3388	50	28	cerebellar	cerebellar	ADJ
fnp-3388	50	29	white	white	ADJ
fnp-3388	50	30	matter	matter	NOUN
fnp-3388	50	31	,	,	PUNCT
fnp-3388	50	32	suggesting	suggest	VERB
fnp-3388	50	33	ongoing	ongoing	ADJ
fnp-3388	50	34	demyelination	demyelination	NOUN
fnp-3388	50	35	,	,	PUNCT
fnp-3388	50	36	but	but	CCONJ
fnp-3388	50	37	no	no	DET
fnp-3388	50	38	evidence	evidence	NOUN
fnp-3388	50	39	to	to	PART
fnp-3388	50	40	suggest	suggest	VERB
fnp-3388	50	41	hemorrhages	hemorrhage	NOUN
fnp-3388	50	42	.	.	PUNCT
fnp-3388	51	1	three	three	NUM
fnp-3388	51	2	weeks	week	NOUN
fnp-3388	51	3	later	later	ADV
fnp-3388	51	4	,	,	PUNCT
fnp-3388	51	5	there	there	PRON
fnp-3388	51	6	was	be	VERB
fnp-3388	51	7	vacuolating	vacuolating	NOUN
fnp-3388	51	8	necrosis	necrosis	NOUN
fnp-3388	51	9	in	in	ADP
fnp-3388	51	10	bilateral	bilateral	ADJ
fnp-3388	51	11	basal	basal	ADJ
fnp-3388	51	12	ganglia	ganglia	NOUN
fnp-3388	51	13	.	.	PUNCT
fnp-3388	52	1	ventriculoperitoneal	ventriculoperitoneal	NOUN
fnp-3388	52	2	shunt	shunt	NOUN
fnp-3388	52	3	placement	placement	NOUN
fnp-3388	52	4	and	and	CCONJ
fnp-3388	52	5	stereotactic	stereotactic	ADJ
fnp-3388	52	6	brain	brain	NOUN
fnp-3388	52	7	biopsy	biopsy	NOUN
fnp-3388	52	8	were	be	AUX
fnp-3388	52	9	performed	perform	VERB
fnp-3388	52	10	on	on	ADP
fnp-3388	52	11	hospital	hospital	NOUN
fnp-3388	52	12	day	day	NOUN
fnp-3388	52	13	48	48	NUM
fnp-3388	52	14	.	.	PUNCT
fnp-3388	53	1	neuropathological	neuropathological	ADJ
fnp-3388	53	2	examination	examination	NOUN
fnp-3388	53	3	of	of	ADP
fnp-3388	53	4	the	the	DET
fnp-3388	53	5	brain	brain	NOUN
fnp-3388	53	6	biopsy	biopsy	NOUN
fnp-3388	53	7	tissue	tissue	NOUN
fnp-3388	53	8	revealed	reveal	VERB
fnp-3388	53	9	subcortical	subcortical	ADJ
fnp-3388	53	10	white	white	ADJ
fnp-3388	53	11	matter	matter	NOUN
fnp-3388	53	12	pallor	pallor	NOUN
fnp-3388	53	13	with	with	ADP
fnp-3388	53	14	perivascular	perivascular	ADJ
fnp-3388	53	15	lymphocytic	lymphocytic	ADJ
fnp-3388	53	16	infiltrates	infiltrate	NOUN
fnp-3388	53	17	centered	center	VERB
fnp-3388	53	18	primarily	primarily	ADV
fnp-3388	53	19	around	around	ADP
fnp-3388	53	20	venules	venule	NOUN
fnp-3388	53	21	(	(	PUNCT
fnp-3388	53	22	figure	figure	NOUN
fnp-3388	53	23	1a	1a	NOUN
fnp-3388	53	24	)	)	PUNCT
fnp-3388	53	25	.	.	PUNCT
fnp-3388	54	1	immunohistochemical	immunohistochemical	ADJ
fnp-3388	54	2	staining	stain	VERB
fnp-3388	54	3	for	for	ADP
fnp-3388	54	4	sars	sar	NOUN
fnp-3388	54	5	-	-	PUNCT
fnp-3388	54	6	cov-2	cov-2	NOUN
fnp-3388	54	7	spike	spike	ADJ
fnp-3388	54	8	protein	protein	NOUN
fnp-3388	54	9	was	be	AUX
fnp-3388	54	10	negative	negative	ADJ
fnp-3388	54	11	.	.	PUNCT
fnp-3388	55	1	no	no	DET
fnp-3388	55	2	microglial	microglial	ADJ
fnp-3388	55	3	nodules	nodule	NOUN
fnp-3388	55	4	or	or	CCONJ
fnp-3388	55	5	evidence	evidence	NOUN
fnp-3388	55	6	of	of	ADP
fnp-3388	55	7	neuronophagia	neuronophagia	NOUN
fnp-3388	55	8	was	be	AUX
fnp-3388	55	9	present	present	ADJ
fnp-3388	55	10	.	.	PUNCT
fnp-3388	56	1	demyelination	demyelination	NOUN
fnp-3388	56	2	was	be	AUX
fnp-3388	56	3	confirmed	confirm	VERB
fnp-3388	56	4	by	by	ADP
fnp-3388	56	5	lfb	lfb	PROPN
fnp-3388	56	6	stain	stain	NOUN
fnp-3388	56	7	(	(	PUNCT
fnp-3388	56	8	figure	figure	NOUN
fnp-3388	56	9	1b	1b	NUM
fnp-3388	56	10	)	)	PUNCT
fnp-3388	56	11	whereas	whereas	SCONJ
fnp-3388	56	12	axons	axon	NOUN
fnp-3388	56	13	were	be	AUX
fnp-3388	56	14	relatively	relatively	ADV
fnp-3388	56	15	preserved	preserve	VERB
fnp-3388	56	16	as	as	SCONJ
fnp-3388	56	17	shown	show	VERB
fnp-3388	56	18	by	by	ADP
fnp-3388	56	19	neurofilament	neurofilament	ADJ
fnp-3388	56	20	immunostain	immunostain	NOUN
fnp-3388	56	21	(	(	PUNCT
fnp-3388	56	22	figure	figure	NOUN
fnp-3388	56	23	1c	1c	NOUN
fnp-3388	56	24	)	)	PUNCT
fnp-3388	56	25	.	.	PUNCT
fnp-3388	57	1	interestingly	interestingly	ADV
fnp-3388	57	2	,	,	PUNCT
fnp-3388	57	3	app	app	PROPN
fnp-3388	57	4	immunostain	immunostain	PROPN
fnp-3388	57	5	highlighted	highlight	VERB
fnp-3388	57	6	damaged	damage	VERB
fnp-3388	57	7	,	,	PUNCT
fnp-3388	57	8	swollen	swollen	ADJ
fnp-3388	57	9	axons	axon	NOUN
fnp-3388	57	10	in	in	ADP
fnp-3388	57	11	areas	area	NOUN
fnp-3388	57	12	surrounding	surround	VERB
fnp-3388	57	13	the	the	DET
fnp-3388	57	14	vessels	vessel	NOUN
fnp-3388	57	15	,	,	PUNCT
fnp-3388	57	16	a	a	DET
fnp-3388	57	17	pattern	pattern	NOUN
fnp-3388	57	18	seen	see	VERB
fnp-3388	57	19	in	in	ADP
fnp-3388	57	20	adult	adult	NOUN
fnp-3388	57	21	patient	patient	NOUN
fnp-3388	57	22	as	as	ADV
fnp-3388	57	23	well	well	ADV
fnp-3388	57	24	(	(	PUNCT
fnp-3388	57	25	figure	figure	NOUN
fnp-3388	57	26	1d	1d	NUM
fnp-3388	57	27	)	)	PUNCT
fnp-3388	57	28	.	.	PUNCT
fnp-3388	58	1	the	the	DET
fnp-3388	58	2	lymphocytes	lymphocyte	NOUN
fnp-3388	58	3	were	be	AUX
fnp-3388	58	4	composed	compose	VERB
fnp-3388	58	5	predominantly	predominantly	ADV
fnp-3388	58	6	of	of	ADP
fnp-3388	58	7	cd3	cd3	ADJ
fnp-3388	58	8	-	-	ADJ
fnp-3388	58	9	positive	positive	ADJ
fnp-3388	58	10	t	t	NOUN
fnp-3388	58	11	cells	cell	NOUN
fnp-3388	58	12	(	(	PUNCT
fnp-3388	58	13	figure	figure	NOUN
fnp-3388	58	14	1e	1e	NUM
fnp-3388	58	15	)	)	PUNCT
fnp-3388	58	16	whereas	whereas	SCONJ
fnp-3388	58	17	cd68	cd68	PROPN
fnp-3388	58	18	stain	stain	NOUN
fnp-3388	58	19	highlighted	highlight	VERB
fnp-3388	58	20	numerous	numerous	ADJ
fnp-3388	58	21	perivascular	perivascular	ADJ
fnp-3388	58	22	macrophages	macrophage	NOUN
fnp-3388	58	23	and	and	CCONJ
fnp-3388	58	24	the	the	DET
fnp-3388	58	25	diffuse	diffuse	ADJ
fnp-3388	58	26	distribution	distribution	NOUN
fnp-3388	58	27	of	of	ADP
fnp-3388	58	28	activated	activate	VERB
fnp-3388	58	29	microglia	microglia	NOUN
fnp-3388	58	30	(	(	PUNCT
fnp-3388	58	31	figure	figure	NOUN
fnp-3388	58	32	1f	1f	NUM
fnp-3388	58	33	)	)	PUNCT
fnp-3388	58	34	.	.	PUNCT
fnp-3388	59	1	figure	figure	NOUN
fnp-3388	59	2	1	1	NUM
fnp-3388	59	3	.	.	PUNCT
fnp-3388	59	4	neuropathological	neuropathological	ADJ
fnp-3388	59	5	findings	finding	NOUN
fnp-3388	59	6	of	of	ADP
fnp-3388	59	7	a	a	DET
fnp-3388	59	8	brain	brain	NOUN
fnp-3388	59	9	biopsy	biopsy	NOUN
fnp-3388	59	10	from	from	ADP
fnp-3388	59	11	a	a	DET
fnp-3388	59	12	child	child	NOUN
fnp-3388	59	13	post	post	NOUN
fnp-3388	59	14	sars	sar	NOUN
fnp-3388	59	15	-	-	PUNCT
fnp-3388	59	16	cov-2	cov-2	NOUN
fnp-3388	59	17	infection	infection	NOUN
fnp-3388	59	18	.	.	PUNCT
fnp-3388	60	1	a.	a.	PROPN
fnp-3388	60	2	h&e	h&e	PROPN
fnp-3388	60	3	section	section	NOUN
fnp-3388	60	4	of	of	ADP
fnp-3388	60	5	white	white	ADJ
fnp-3388	60	6	matter	matter	NOUN
fnp-3388	60	7	pallor	pallor	NOUN
fnp-3388	60	8	,	,	PUNCT
fnp-3388	60	9	reactive	reactive	ADJ
fnp-3388	60	10	astrogliosis	astrogliosis	NOUN
fnp-3388	60	11	and	and	CCONJ
fnp-3388	60	12	perivascular	perivascular	ADJ
fnp-3388	60	13	lymphocytic	lymphocytic	ADJ
fnp-3388	60	14	infiltrates	infiltrate	NOUN
fnp-3388	60	15	around	around	ADP
fnp-3388	60	16	small	small	ADJ
fnp-3388	60	17	veins	vein	NOUN
fnp-3388	60	18	and	and	CCONJ
fnp-3388	60	19	venules	venule	NOUN
fnp-3388	60	20	.	.	PUNCT
fnp-3388	61	1	b.	b.	PROPN
fnp-3388	61	2	lfb	lfb	PROPN
fnp-3388	61	3	stain	stain	NOUN
fnp-3388	61	4	demonstrates	demonstrate	VERB
fnp-3388	61	5	the	the	DET
fnp-3388	61	6	perivascular	perivascular	ADJ
fnp-3388	61	7	myelin	myelin	NOUN
fnp-3388	61	8	loss	loss	NOUN
fnp-3388	61	9	within	within	ADP
fnp-3388	61	10	the	the	DET
fnp-3388	61	11	subcortical	subcortical	ADJ
fnp-3388	61	12	white	white	ADJ
fnp-3388	61	13	matter	matter	NOUN
fnp-3388	61	14	lesion	lesion	NOUN
fnp-3388	61	15	.	.	PUNCT
fnp-3388	62	1	c.	c.	PROPN
fnp-3388	62	2	neurofilament	neurofilament	PROPN
fnp-3388	62	3	immunostain	immunostain	PROPN
fnp-3388	62	4	shows	show	VERB
fnp-3388	62	5	preservation	preservation	NOUN
fnp-3388	62	6	of	of	ADP
fnp-3388	62	7	most	most	ADJ
fnp-3388	62	8	axons	axon	NOUN
fnp-3388	62	9	in	in	ADP
fnp-3388	62	10	the	the	DET
fnp-3388	62	11	region	region	NOUN
fnp-3388	62	12	of	of	ADP
fnp-3388	62	13	myelin	myelin	NOUN
fnp-3388	62	14	loss	loss	NOUN
fnp-3388	62	15	.	.	PUNCT
fnp-3388	63	1	d.	d.	PROPN
fnp-3388	63	2	app	app	PROPN
fnp-3388	63	3	immunostain	immunostain	PROPN
fnp-3388	63	4	identifies	identify	VERB
fnp-3388	63	5	axonal	axonal	ADJ
fnp-3388	63	6	swellings	swelling	NOUN
fnp-3388	63	7	adjacent	adjacent	ADJ
fnp-3388	63	8	to	to	ADP
fnp-3388	63	9	the	the	DET
fnp-3388	63	10	perivascular	perivascular	ADJ
fnp-3388	63	11	areas	area	NOUN
fnp-3388	63	12	.	.	PUNCT
fnp-3388	64	1	e.	e.	PROPN
fnp-3388	64	2	perivascular	perivascular	PROPN
fnp-3388	64	3	lymphocytes	lymphocyte	NOUN
fnp-3388	64	4	are	be	AUX
fnp-3388	64	5	predominantly	predominantly	ADV
fnp-3388	64	6	cd3	cd3	VERB
fnp-3388	64	7	-	-	ADJ
fnp-3388	64	8	positive	positive	ADJ
fnp-3388	64	9	t	t	NOUN
fnp-3388	64	10	cell	cell	NOUN
fnp-3388	64	11	.	.	PUNCT
fnp-3388	65	1	f.	f.	PROPN
fnp-3388	66	1	cd68	cd68	PROPN
fnp-3388	66	2	immunostain	immunostain	NOUN
fnp-3388	66	3	confirms	confirm	VERB
fnp-3388	66	4	both	both	CCONJ
fnp-3388	66	5	perivascular	perivascular	ADJ
fnp-3388	66	6	and	and	CCONJ
fnp-3388	66	7	diffuse	diffuse	VERB
fnp-3388	66	8	distributions	distribution	NOUN
fnp-3388	66	9	of	of	ADP
fnp-3388	66	10	macrophages	macrophage	NOUN
fnp-3388	66	11	within	within	ADP
fnp-3388	66	12	the	the	DET
fnp-3388	66	13	area	area	NOUN
fnp-3388	66	14	of	of	ADP
fnp-3388	66	15	white	white	ADJ
fnp-3388	66	16	matter	matter	NOUN
fnp-3388	66	17	pallor	pallor	NOUN
fnp-3388	66	18	.	.	PUNCT
fnp-3388	67	1	scale	scale	NOUN
fnp-3388	67	2	bar	bar	NOUN
fnp-3388	67	3	,	,	PUNCT
fnp-3388	67	4	100	100	NUM
fnp-3388	67	5	μm	μm	NOUN
fnp-3388	67	6	in	in	ADP
fnp-3388	67	7	a	a	DET
fnp-3388	67	8	-	-	INTJ
fnp-3388	67	9	e.	e.	NOUN
fnp-3388	67	10	in	in	ADP
fnp-3388	67	11	this	this	DET
fnp-3388	67	12	case	case	NOUN
fnp-3388	67	13	,	,	PUNCT
fnp-3388	67	14	the	the	DET
fnp-3388	67	15	absence	absence	NOUN
fnp-3388	67	16	of	of	ADP
fnp-3388	67	17	confounding	confound	VERB
fnp-3388	67	18	concomitant	concomitant	ADJ
fnp-3388	67	19	cerebrovascular	cerebrovascular	ADJ
fnp-3388	67	20	lesions	lesion	NOUN
fnp-3388	67	21	makes	make	VERB
fnp-3388	67	22	the	the	DET
fnp-3388	67	23	pathological	pathological	ADJ
fnp-3388	67	24	interpretation	interpretation	NOUN
fnp-3388	67	25	relatively	relatively	ADV
fnp-3388	67	26	straightforward	straightforward	ADJ
fnp-3388	67	27	.	.	PUNCT
fnp-3388	68	1	these	these	DET
fnp-3388	68	2	adem	adem	PROPN
fnp-3388	68	3	/	/	SYM
fnp-3388	68	4	ahle	ahle	ADJ
fnp-3388	68	5	cases	case	NOUN
fnp-3388	68	6	represent	represent	VERB
fnp-3388	68	7	rare	rare	ADJ
fnp-3388	68	8	,	,	PUNCT
fnp-3388	68	9	but	but	CCONJ
fnp-3388	68	10	the	the	DET
fnp-3388	68	11	most	most	ADV
fnp-3388	68	12	severe	severe	ADJ
fnp-3388	68	13	end	end	NOUN
fnp-3388	68	14	of	of	ADP
fnp-3388	68	15	the	the	DET
fnp-3388	68	16	covid-19	covid-19	PROPN
fnp-3388	68	17	neuropathologic	neuropathologic	ADJ
fnp-3388	68	18	spectrum	spectrum	NOUN
fnp-3388	68	19	.	.	PUNCT
fnp-3388	69	1	consequently	consequently	ADV
fnp-3388	69	2	,	,	PUNCT
fnp-3388	69	3	adem	adem	PROPN
fnp-3388	69	4	/	/	SYM
fnp-3388	69	5	ahle	ahle	PROPN
fnp-3388	69	6	should	should	AUX
fnp-3388	69	7	be	be	AUX
fnp-3388	69	8	a	a	DET
fnp-3388	69	9	consideration	consideration	NOUN
fnp-3388	69	10	during	during	ADP
fnp-3388	69	11	evaluation	evaluation	NOUN
fnp-3388	69	12	of	of	ADP
fnp-3388	69	13	patients	patient	NOUN
fnp-3388	69	14	,	,	PUNCT
fnp-3388	69	15	especially	especially	ADV
fnp-3388	69	16	children	child	NOUN
fnp-3388	69	17	with	with	ADP
fnp-3388	69	18	encephalopathy	encephalopathy	ADJ
fnp-3388	69	19	,	,	PUNCT
fnp-3388	69	20	seizures	seizure	NOUN
fnp-3388	69	21	and/or	and/or	CCONJ
fnp-3388	69	22	focal	focal	ADJ
fnp-3388	69	23	neurologic	neurologic	ADJ
fnp-3388	69	24	deficits	deficit	NOUN
fnp-3388	69	25	after	after	ADP
fnp-3388	69	26	recovering	recover	VERB
fnp-3388	69	27	from	from	ADP
fnp-3388	69	28	covid-19	covid-19	PROPN
fnp-3388	69	29	.	.	PUNCT
fnp-3388	70	1	another	another	DET
fnp-3388	70	2	intriguing	intriguing	ADJ
fnp-3388	70	3	development	development	NOUN
fnp-3388	70	4	in	in	ADP
fnp-3388	70	5	this	this	DET
fnp-3388	70	6	pediatric	pediatric	ADJ
fnp-3388	70	7	patient	patient	NOUN
fnp-3388	70	8	is	be	AUX
fnp-3388	70	9	the	the	DET
fnp-3388	70	10	later	late	ADJ
fnp-3388	70	11	mri	mri	NOUN
fnp-3388	70	12	findings	finding	NOUN
fnp-3388	70	13	of	of	ADP
fnp-3388	70	14	bilateral	bilateral	ADJ
fnp-3388	70	15	basal	basal	ADJ
fnp-3388	70	16	ganglia	ganglia	NOUN
fnp-3388	70	17	necrosis	necrosis	NOUN
fnp-3388	70	18	,	,	PUNCT
fnp-3388	70	19	suggestive	suggestive	ADJ
fnp-3388	70	20	an	an	DET
fnp-3388	70	21	even	even	ADV
fnp-3388	70	22	rarer	rare	ADJ
fnp-3388	70	23	entity	entity	NOUN
fnp-3388	70	24	,	,	PUNCT
fnp-3388	70	25	acute	acute	ADJ
fnp-3388	70	26	necrotizing	necrotizing	NOUN
fnp-3388	70	27	encephalopathy	encephalopathy	NOUN
fnp-3388	70	28	(	(	PUNCT
fnp-3388	70	29	ane	ane	NOUN
fnp-3388	70	30	)	)	PUNCT
fnp-3388	70	31	,	,	PUNCT
fnp-3388	70	32	also	also	ADV
fnp-3388	70	33	referred	refer	VERB
fnp-3388	70	34	as	as	ADP
fnp-3388	70	35	acute	acute	ADJ
fnp-3388	70	36	necrotizing	necrotizing	NOUN
fnp-3388	70	37	encephalopathy	encephalopathy	NOUN
fnp-3388	70	38	of	of	ADP
fnp-3388	70	39	childhood	childhood	NOUN
fnp-3388	70	40	.	.	PUNCT
fnp-3388	71	1	ane	ane	NOUN
fnp-3388	71	2	is	be	AUX
fnp-3388	71	3	characterized	characterize	VERB
fnp-3388	71	4	by	by	ADP
fnp-3388	71	5	multiple	multiple	ADJ
fnp-3388	71	6	,	,	PUNCT
fnp-3388	71	7	symmetrical	symmetrical	ADJ
fnp-3388	71	8	lesions	lesion	NOUN
fnp-3388	71	9	in	in	ADP
fnp-3388	71	10	the	the	DET
fnp-3388	71	11	thalami	thalami	NOUN
fnp-3388	71	12	,	,	PUNCT
fnp-3388	71	13	striatum	striatum	NOUN
fnp-3388	71	14	,	,	PUNCT
fnp-3388	71	15	cerebral	cerebral	ADJ
fnp-3388	71	16	white	white	ADJ
fnp-3388	71	17	matter	matter	NOUN
fnp-3388	71	18	,	,	PUNCT
fnp-3388	71	19	and	and	CCONJ
fnp-3388	71	20	brain	brain	NOUN
fnp-3388	71	21	stem	stem	NOUN
fnp-3388	71	22	[	[	X
fnp-3388	71	23	38	38	NUM
fnp-3388	71	24	]	]	PUNCT
fnp-3388	71	25	.	.	PUNCT
fnp-3388	72	1	despite	despite	SCONJ
fnp-3388	72	2	its	its	PRON
fnp-3388	72	3	association	association	NOUN
fnp-3388	72	4	with	with	ADP
fnp-3388	72	5	viral	viral	ADJ
fnp-3388	72	6	infection	infection	NOUN
fnp-3388	72	7	,	,	PUNCT
fnp-3388	72	8	ane	ane	NOUN
fnp-3388	72	9	is	be	AUX
fnp-3388	72	10	not	not	PART
fnp-3388	72	11	considered	consider	VERB
fnp-3388	72	12	an	an	DET
fnp-3388	72	13	inflammatory	inflammatory	ADJ
fnp-3388	72	14	encephalitis	encephalitis	NOUN
fnp-3388	72	15	in	in	ADP
fnp-3388	72	16	comparison	comparison	NOUN
fnp-3388	72	17	to	to	ADP
fnp-3388	72	18	adem	adem	PROPN
fnp-3388	72	19	and	and	CCONJ
fnp-3388	72	20	ahle	ahle	ADJ
fnp-3388	72	21	.	.	PUNCT
fnp-3388	73	1	in	in	ADP
fnp-3388	73	2	fact	fact	NOUN
fnp-3388	73	3	,	,	PUNCT
fnp-3388	73	4	it	it	PRON
fnp-3388	73	5	has	have	AUX
fnp-3388	73	6	been	be	AUX
fnp-3388	73	7	suggested	suggest	VERB
fnp-3388	73	8	that	that	SCONJ
fnp-3388	73	9	an	an	DET
fnp-3388	73	10	intense	intense	ADJ
fnp-3388	73	11	surge	surge	NOUN
fnp-3388	73	12	of	of	ADP
fnp-3388	73	13	cytokines	cytokine	NOUN
fnp-3388	73	14	causes	cause	VERB
fnp-3388	73	15	damage	damage	NOUN
fnp-3388	73	16	to	to	ADP
fnp-3388	73	17	the	the	DET
fnp-3388	73	18	blood	blood	NOUN
fnp-3388	73	19	-	-	PUNCT
fnp-3388	73	20	brain	brain	NOUN
fnp-3388	73	21	barrier	barrier	NOUN
fnp-3388	73	22	with	with	ADP
fnp-3388	73	23	necrosis	necrosis	NOUN
fnp-3388	73	24	as	as	ADP
fnp-3388	73	25	a	a	DET
fnp-3388	73	26	secondary	secondary	ADJ
fnp-3388	73	27	effect	effect	NOUN
fnp-3388	73	28	[	[	X
fnp-3388	73	29	39	39	NUM
fnp-3388	73	30	]	]	PUNCT
fnp-3388	73	31	.	.	PUNCT
fnp-3388	74	1	given	give	VERB
fnp-3388	74	2	sars	sar	NOUN
fnp-3388	74	3	-	-	PUNCT
fnp-3388	74	4	cov-2	cov-2	NUM
fnp-3388	74	5	is	be	AUX
fnp-3388	74	6	a	a	DET
fnp-3388	74	7	cytokine	cytokine	ADJ
fnp-3388	74	8	storm	storm	NOUN
fnp-3388	74	9	trigger	trigger	NOUN
fnp-3388	74	10	,	,	PUNCT
fnp-3388	74	11	it	it	PRON
fnp-3388	74	12	is	be	AUX
fnp-3388	74	13	not	not	PART
fnp-3388	74	14	surprising	surprising	ADJ
fnp-3388	74	15	to	to	PART
fnp-3388	74	16	observe	observe	VERB
fnp-3388	74	17	ane	ane	NOUN
fnp-3388	74	18	as	as	ADP
fnp-3388	74	19	a	a	DET
fnp-3388	74	20	probable	probable	ADJ
fnp-3388	74	21	association	association	NOUN
fnp-3388	74	22	of	of	ADP
fnp-3388	74	23	covid-19	covid-19	PROPN
fnp-3388	75	1	[	[	X
fnp-3388	75	2	40	40	NUM
fnp-3388	75	3	,	,	PUNCT
fnp-3388	75	4	41	41	NUM
fnp-3388	75	5	]	]	PUNCT
fnp-3388	75	6	.	.	PUNCT
fnp-3388	76	1	it	it	PRON
fnp-3388	76	2	would	would	AUX
fnp-3388	76	3	be	be	AUX
fnp-3388	76	4	important	important	ADJ
fnp-3388	76	5	to	to	PART
fnp-3388	76	6	understand	understand	VERB
fnp-3388	76	7	whether	whether	SCONJ
fnp-3388	76	8	these	these	DET
fnp-3388	76	9	parainfectious	parainfectious	ADJ
fnp-3388	76	10	demyelinating	demyelinate	VERB
fnp-3388	76	11	diseases	disease	NOUN
fnp-3388	76	12	reflect	reflect	VERB
fnp-3388	76	13	distinct	distinct	ADJ
fnp-3388	76	14	pathological	pathological	ADJ
fnp-3388	76	15	processes	process	NOUN
fnp-3388	76	16	or	or	CCONJ
fnp-3388	76	17	a	a	DET
fnp-3388	76	18	continuum	continuum	NOUN
fnp-3388	76	19	of	of	ADP
fnp-3388	76	20	a	a	DET
fnp-3388	76	21	single	single	ADJ
fnp-3388	76	22	disease	disease	NOUN
fnp-3388	76	23	.	.	PUNCT
fnp-3388	76	24	  	  	SPACE
fnp-3388	76	25	references	reference	NOUN
fnp-3388	76	26	1	1	NUM
fnp-3388	76	27	.	.	PUNCT
fnp-3388	77	1	zhu	zhu	PROPN
fnp-3388	77	2	,	,	PUNCT
fnp-3388	77	3	n.	n.	PROPN
fnp-3388	77	4	,	,	PUNCT
fnp-3388	77	5	et	et	PROPN
fnp-3388	77	6	al	al	PROPN
fnp-3388	77	7	.	.	PROPN
fnp-3388	77	8	,	,	PUNCT
fnp-3388	77	9	a	a	DET
fnp-3388	77	10	novel	novel	ADJ
fnp-3388	77	11	coronavirus	coronavirus	NOUN
fnp-3388	77	12	from	from	ADP
fnp-3388	77	13	patients	patient	NOUN
fnp-3388	77	14	with	with	ADP
fnp-3388	77	15	pneumonia	pneumonia	NOUN
fnp-3388	77	16	in	in	ADP
fnp-3388	77	17	china	china	PROPN
fnp-3388	77	18	,	,	PUNCT
fnp-3388	77	19	2019	2019	NUM
fnp-3388	77	20	.	.	PUNCT
fnp-3388	78	1	n	n	X
fnp-3388	78	2	engl	engl	PROPN
fnp-3388	78	3	j	j	PROPN
fnp-3388	78	4	med	med	PROPN
fnp-3388	78	5	,	,	PUNCT
fnp-3388	78	6	2020	2020	NUM
fnp-3388	78	7	.	.	PUNCT
fnp-3388	79	1	382(8	382(8	NUM
fnp-3388	79	2	):	):	PUNCT
fnp-3388	79	3	p.	p.	NOUN
fnp-3388	79	4	727	727	NUM
fnp-3388	79	5	-	-	SYM
fnp-3388	79	6	733	733	NUM
fnp-3388	79	7	.	.	PUNCT
fnp-3388	80	1	2	2	NUM
fnp-3388	80	2	.	.	X
fnp-3388	80	3	lou	lou	PROPN
fnp-3388	80	4	,	,	PUNCT
fnp-3388	80	5	j.j	j.j	PROPN
fnp-3388	80	6	.	.	PROPN
fnp-3388	80	7	,	,	PUNCT
fnp-3388	80	8	et	et	PROPN
fnp-3388	80	9	al	al	PROPN
fnp-3388	80	10	.	.	PROPN
fnp-3388	80	11	,	,	PUNCT
fnp-3388	80	12	neuropathology	neuropathology	NOUN
fnp-3388	80	13	of	of	ADP
fnp-3388	80	14	covid-19	covid-19	PROPN
fnp-3388	80	15	(	(	PUNCT
fnp-3388	80	16	neuro	neuro	NOUN
fnp-3388	80	17	-	-	PUNCT
fnp-3388	80	18	covid	covid	PROPN
fnp-3388	80	19	):	):	PUNCT
fnp-3388	80	20	clinicopathological	clinicopathological	ADJ
fnp-3388	80	21	update	update	NOUN
fnp-3388	80	22	.	.	PUNCT
fnp-3388	81	1	free	free	ADJ
fnp-3388	81	2	neuropathol	neuropathol	NOUN
fnp-3388	81	3	,	,	PUNCT
fnp-3388	81	4	2021	2021	NUM
fnp-3388	81	5	.	.	PUNCT
fnp-3388	82	1	2	2	NUM
fnp-3388	82	2	.	.	NOUN
fnp-3388	82	3	3	3	NUM
fnp-3388	82	4	.	.	X
fnp-3388	82	5	lechien	lechien	PROPN
fnp-3388	82	6	,	,	PUNCT
fnp-3388	82	7	j.r	j.r	PROPN
fnp-3388	82	8	.	.	PROPN
fnp-3388	82	9	,	,	PUNCT
fnp-3388	82	10	et	et	PROPN
fnp-3388	82	11	al	al	PROPN
fnp-3388	82	12	.	.	PROPN
fnp-3388	82	13	,	,	PUNCT
fnp-3388	82	14	olfactory	olfactory	NOUN
fnp-3388	82	15	and	and	CCONJ
fnp-3388	82	16	gustatory	gustatory	NOUN
fnp-3388	82	17	dysfunctions	dysfunction	NOUN
fnp-3388	82	18	as	as	ADP
fnp-3388	82	19	a	a	DET
fnp-3388	82	20	clinical	clinical	ADJ
fnp-3388	82	21	presentation	presentation	NOUN
fnp-3388	82	22	of	of	ADP
fnp-3388	82	23	mild	mild	ADJ
fnp-3388	82	24	-	-	PUNCT
fnp-3388	82	25	to	to	ADP
fnp-3388	82	26	-	-	PUNCT
fnp-3388	82	27	moderate	moderate	ADJ
fnp-3388	82	28	forms	form	NOUN
fnp-3388	82	29	of	of	ADP
fnp-3388	82	30	the	the	DET
fnp-3388	82	31	coronavirus	coronavirus	NOUN
fnp-3388	82	32	disease	disease	NOUN
fnp-3388	82	33	(	(	PUNCT
fnp-3388	82	34	covid-19	covid-19	PROPN
fnp-3388	82	35	):	):	PUNCT
fnp-3388	82	36	a	a	DET
fnp-3388	82	37	multicenter	multicenter	ADJ
fnp-3388	82	38	european	european	ADJ
fnp-3388	82	39	study	study	NOUN
fnp-3388	82	40	.	.	PUNCT
fnp-3388	83	1	eur	eur	PROPN
fnp-3388	83	2	arch	arch	ADJ
fnp-3388	83	3	otorhinolaryngol	otorhinolaryngol	NOUN
fnp-3388	83	4	,	,	PUNCT
fnp-3388	83	5	2020	2020	NUM
fnp-3388	83	6	.	.	PUNCT
fnp-3388	84	1	277(8	277(8	NUM
fnp-3388	84	2	):	):	PUNCT
fnp-3388	84	3	p.	p.	NOUN
fnp-3388	84	4	2251	2251	NUM
fnp-3388	84	5	-	-	SYM
fnp-3388	84	6	2261	2261	NUM
fnp-3388	84	7	.	.	PUNCT
fnp-3388	85	1	4	4	NUM
fnp-3388	85	2	.	.	X
fnp-3388	85	3	merkler	merkler	NOUN
fnp-3388	85	4	,	,	PUNCT
fnp-3388	85	5	a.e	a.e	PROPN
fnp-3388	85	6	.	.	PROPN
fnp-3388	85	7	,	,	PUNCT
fnp-3388	85	8	et	et	PROPN
fnp-3388	85	9	al	al	PROPN
fnp-3388	85	10	.	.	PROPN
fnp-3388	85	11	,	,	PUNCT
fnp-3388	85	12	risk	risk	NOUN
fnp-3388	85	13	of	of	ADP
fnp-3388	85	14	ischemic	ischemic	ADJ
fnp-3388	85	15	stroke	stroke	NOUN
fnp-3388	85	16	in	in	ADP
fnp-3388	85	17	patients	patient	NOUN
fnp-3388	85	18	with	with	ADP
fnp-3388	85	19	coronavirus	coronavirus	NOUN
fnp-3388	85	20	disease	disease	NOUN
fnp-3388	85	21	2019	2019	NUM
fnp-3388	85	22	(	(	PUNCT
fnp-3388	85	23	covid-19	covid-19	PROPN
fnp-3388	85	24	)	)	PUNCT
fnp-3388	85	25	vs	vs	ADP
fnp-3388	85	26	patients	patient	NOUN
fnp-3388	85	27	with	with	ADP
fnp-3388	85	28	influenza	influenza	NOUN
fnp-3388	85	29	.	.	PUNCT
fnp-3388	86	1	jama	jama	PROPN
fnp-3388	86	2	neurol	neurol	PROPN
fnp-3388	86	3	,	,	PUNCT
fnp-3388	86	4	2020	2020	NUM
fnp-3388	86	5	.	.	PUNCT
fnp-3388	87	1	5	5	X
fnp-3388	87	2	.	.	X
fnp-3388	87	3	dogra	dogra	PROPN
fnp-3388	87	4	,	,	PUNCT
fnp-3388	87	5	s.	s.	PROPN
fnp-3388	87	6	,	,	PUNCT
fnp-3388	87	7	et	et	PROPN
fnp-3388	87	8	al	al	PROPN
fnp-3388	87	9	.	.	PROPN
fnp-3388	87	10	,	,	PUNCT
fnp-3388	87	11	hemorrhagic	hemorrhagic	NOUN
fnp-3388	87	12	stroke	stroke	NOUN
fnp-3388	87	13	and	and	CCONJ
fnp-3388	87	14	anticoagulation	anticoagulation	NOUN
fnp-3388	87	15	in	in	ADP
fnp-3388	87	16	covid-19	covid-19	PROPN
fnp-3388	87	17	.	.	PUNCT
fnp-3388	88	1	j	j	PROPN
fnp-3388	88	2	stroke	stroke	PROPN
fnp-3388	88	3	cerebrovasc	cerebrovasc	PROPN
fnp-3388	88	4	dis	dis	PROPN
fnp-3388	88	5	,	,	PUNCT
fnp-3388	88	6	2020	2020	NUM
fnp-3388	88	7	.	.	PUNCT
fnp-3388	89	1	29(8	29(8	NUM
fnp-3388	89	2	):	):	PUNCT
fnp-3388	89	3	p.	p.	NOUN
fnp-3388	89	4	104984	104984	NUM
fnp-3388	89	5	.	.	PUNCT
fnp-3388	90	1	6	6	NUM
fnp-3388	90	2	.	.	X
fnp-3388	90	3	fodoulian	fodoulian	PROPN
fnp-3388	90	4	,	,	PUNCT
fnp-3388	90	5	l.	l.	PROPN
fnp-3388	90	6	,	,	PUNCT
fnp-3388	90	7	et	et	PROPN
fnp-3388	90	8	al	al	PROPN
fnp-3388	90	9	.	.	PROPN
fnp-3388	90	10	,	,	PUNCT
fnp-3388	90	11	sars	sars	PROPN
fnp-3388	90	12	-	-	PUNCT
fnp-3388	90	13	cov-2	cov-2	PART
fnp-3388	90	14	receptors	receptor	NOUN
fnp-3388	90	15	and	and	CCONJ
fnp-3388	90	16	entry	entry	NOUN
fnp-3388	90	17	genes	gene	NOUN
fnp-3388	90	18	are	be	AUX
fnp-3388	90	19	expressed	express	VERB
fnp-3388	90	20	in	in	ADP
fnp-3388	90	21	the	the	DET
fnp-3388	90	22	human	human	ADJ
fnp-3388	90	23	olfactory	olfactory	NOUN
fnp-3388	90	24	neuroepithelium	neuroepithelium	NOUN
fnp-3388	90	25	and	and	CCONJ
fnp-3388	90	26	brain	brain	NOUN
fnp-3388	90	27	.	.	PUNCT
fnp-3388	91	1	iscience	iscience	PROPN
fnp-3388	91	2	,	,	PUNCT
fnp-3388	91	3	2020	2020	NUM
fnp-3388	91	4	.	.	PUNCT
fnp-3388	92	1	23(12	23(12	NUM
fnp-3388	92	2	):	):	PUNCT
fnp-3388	92	3	p.	p.	NOUN
fnp-3388	92	4	101839	101839	NUM
fnp-3388	92	5	.	.	PUNCT
fnp-3388	93	1	7	7	X
fnp-3388	93	2	.	.	NUM
fnp-3388	93	3	salamanna	salamanna	NOUN
fnp-3388	93	4	,	,	PUNCT
fnp-3388	93	5	f.	f.	PROPN
fnp-3388	93	6	,	,	PUNCT
fnp-3388	93	7	et	et	PROPN
fnp-3388	93	8	al	al	PROPN
fnp-3388	93	9	.	.	PROPN
fnp-3388	93	10	,	,	PUNCT
fnp-3388	93	11	body	body	NOUN
fnp-3388	93	12	localization	localization	NOUN
fnp-3388	93	13	of	of	ADP
fnp-3388	93	14	ace-2	ace-2	NUM
fnp-3388	93	15	:	:	PUNCT
fnp-3388	93	16	on	on	ADP
fnp-3388	93	17	the	the	DET
fnp-3388	93	18	trail	trail	NOUN
fnp-3388	93	19	of	of	ADP
fnp-3388	93	20	the	the	DET
fnp-3388	93	21	keyhole	keyhole	NOUN
fnp-3388	93	22	of	of	ADP
fnp-3388	93	23	sars	sar	NOUN
fnp-3388	93	24	-	-	PUNCT
fnp-3388	93	25	cov-2	cov-2	NOUN
fnp-3388	93	26	.	.	PUNCT
fnp-3388	93	27	front	front	ADJ
fnp-3388	93	28	med	med	PROPN
fnp-3388	93	29	(	(	PUNCT
fnp-3388	93	30	lausanne	lausanne	PROPN
fnp-3388	93	31	)	)	PUNCT
fnp-3388	93	32	,	,	PUNCT
fnp-3388	93	33	2020	2020	NUM
fnp-3388	93	34	.	.	PUNCT
fnp-3388	94	1	7	7	NUM
fnp-3388	94	2	:	:	PUNCT
fnp-3388	94	3	p.	p.	NOUN
fnp-3388	94	4	594495	594495	NUM
fnp-3388	94	5	.	.	PUNCT
fnp-3388	95	1	8	8	X
fnp-3388	95	2	.	.	PUNCT
fnp-3388	95	3	brann	brann	PROPN
fnp-3388	95	4	,	,	PUNCT
fnp-3388	95	5	d.h	d.h	PROPN
fnp-3388	95	6	.	.	PROPN
fnp-3388	95	7	,	,	PUNCT
fnp-3388	95	8	et	et	PROPN
fnp-3388	95	9	al	al	PROPN
fnp-3388	95	10	.	.	PROPN
fnp-3388	95	11	,	,	PUNCT
fnp-3388	95	12	non	non	ADJ
fnp-3388	95	13	-	-	ADJ
fnp-3388	95	14	neuronal	neuronal	ADJ
fnp-3388	95	15	expression	expression	NOUN
fnp-3388	95	16	of	of	ADP
fnp-3388	95	17	sars	sar	NOUN
fnp-3388	95	18	-	-	PUNCT
fnp-3388	95	19	cov-2	cov-2	NOUN
fnp-3388	95	20	entry	entry	NOUN
fnp-3388	95	21	genes	gene	NOUN
fnp-3388	95	22	in	in	ADP
fnp-3388	95	23	the	the	DET
fnp-3388	95	24	olfactory	olfactory	ADJ
fnp-3388	95	25	system	system	NOUN
fnp-3388	95	26	suggests	suggest	VERB
fnp-3388	95	27	mechanisms	mechanism	NOUN
fnp-3388	95	28	underlying	underlie	VERB
fnp-3388	95	29	covid-19	covid-19	PROPN
fnp-3388	95	30	-	-	PUNCT
fnp-3388	95	31	associated	associate	VERB
fnp-3388	95	32	anosmia	anosmia	NOUN
fnp-3388	95	33	.	.	PUNCT
fnp-3388	96	1	sci	sci	PROPN
fnp-3388	96	2	adv	adv	PROPN
fnp-3388	96	3	,	,	PUNCT
fnp-3388	96	4	2020	2020	NUM
fnp-3388	96	5	.	.	PUNCT
fnp-3388	97	1	6(31	6(31	NUM
fnp-3388	97	2	)	)	PUNCT
fnp-3388	97	3	.	.	PUNCT
fnp-3388	98	1	9	9	X
fnp-3388	98	2	.	.	X
fnp-3388	98	3	xia	xia	PROPN
fnp-3388	98	4	,	,	PUNCT
fnp-3388	98	5	h.	h.	PROPN
fnp-3388	98	6	and	and	CCONJ
fnp-3388	98	7	e.	e.	PROPN
fnp-3388	98	8	lazartigues	lazartigues	PROPN
fnp-3388	98	9	,	,	PUNCT
fnp-3388	98	10	angiotensin	angiotensin	NOUN
fnp-3388	98	11	-	-	PUNCT
fnp-3388	98	12	converting	convert	VERB
fnp-3388	98	13	enzyme	enzyme	NOUN
fnp-3388	98	14	2	2	NUM
fnp-3388	98	15	in	in	ADP
fnp-3388	98	16	the	the	DET
fnp-3388	98	17	brain	brain	NOUN
fnp-3388	98	18	:	:	PUNCT
fnp-3388	98	19	properties	property	NOUN
fnp-3388	98	20	and	and	CCONJ
fnp-3388	98	21	future	future	ADJ
fnp-3388	98	22	directions	direction	NOUN
fnp-3388	98	23	.	.	PUNCT
fnp-3388	99	1	j	j	PROPN
fnp-3388	99	2	neurochem	neurochem	PROPN
fnp-3388	99	3	,	,	PUNCT
fnp-3388	99	4	2008	2008	NUM
fnp-3388	99	5	.	.	PUNCT
fnp-3388	100	1	107(6	107(6	NUM
fnp-3388	100	2	):	):	PUNCT
fnp-3388	100	3	p.	p.	NOUN
fnp-3388	100	4	1482	1482	NUM
fnp-3388	100	5	-	-	SYM
fnp-3388	100	6	1494	1494	NUM
fnp-3388	100	7	.	.	PUNCT
fnp-3388	101	1	10	10	NUM
fnp-3388	101	2	.	.	X
fnp-3388	101	3	gheblawi	gheblawi	PROPN
fnp-3388	101	4	,	,	PUNCT
fnp-3388	101	5	m.	m.	NOUN
fnp-3388	101	6	,	,	PUNCT
fnp-3388	101	7	et	et	PROPN
fnp-3388	101	8	al	al	PROPN
fnp-3388	101	9	.	.	PROPN
fnp-3388	101	10	,	,	PUNCT
fnp-3388	101	11	angiotensin	angiotensin	NOUN
fnp-3388	101	12	-	-	PUNCT
fnp-3388	101	13	converting	convert	VERB
fnp-3388	101	14	enzyme	enzyme	NOUN
fnp-3388	101	15	2	2	NUM
fnp-3388	101	16	:	:	PUNCT
fnp-3388	101	17	sars	sar	NOUN
fnp-3388	101	18	-	-	PUNCT
fnp-3388	101	19	cov-2	cov-2	NOUN
fnp-3388	101	20	receptor	receptor	NOUN
fnp-3388	101	21	and	and	CCONJ
fnp-3388	101	22	regulator	regulator	NOUN
fnp-3388	101	23	of	of	ADP
fnp-3388	101	24	the	the	DET
fnp-3388	101	25	renin	renin	ADJ
fnp-3388	101	26	-	-	PUNCT
fnp-3388	101	27	angiotensin	angiotensin	NOUN
fnp-3388	101	28	system	system	NOUN
fnp-3388	101	29	:	:	PUNCT
fnp-3388	101	30	celebrating	celebrate	VERB
fnp-3388	101	31	the	the	DET
fnp-3388	101	32	20th	20th	ADJ
fnp-3388	101	33	anniversary	anniversary	NOUN
fnp-3388	101	34	of	of	ADP
fnp-3388	101	35	the	the	DET
fnp-3388	101	36	discovery	discovery	NOUN
fnp-3388	101	37	of	of	ADP
fnp-3388	101	38	ace2	ace2	PROPN
fnp-3388	101	39	.	.	PUNCT
fnp-3388	102	1	circ	circ	PROPN
fnp-3388	102	2	res	re	NOUN
fnp-3388	102	3	,	,	PUNCT
fnp-3388	102	4	2020	2020	NUM
fnp-3388	102	5	.	.	PUNCT
fnp-3388	103	1	126(10	126(10	NUM
fnp-3388	103	2	):	):	PUNCT
fnp-3388	103	3	p.	p.	NOUN
fnp-3388	103	4	1456	1456	NUM
fnp-3388	103	5	-	-	SYM
fnp-3388	103	6	1474	1474	NUM
fnp-3388	103	7	.	.	PUNCT
fnp-3388	104	1	11	11	NUM
fnp-3388	104	2	.	.	X
fnp-3388	105	1	meinhardt	meinhardt	PROPN
fnp-3388	105	2	,	,	PUNCT
fnp-3388	105	3	j.	j.	PROPN
fnp-3388	105	4	,	,	PUNCT
fnp-3388	105	5	et	et	PROPN
fnp-3388	105	6	al	al	PROPN
fnp-3388	105	7	.	.	PROPN
fnp-3388	105	8	,	,	PUNCT
fnp-3388	105	9	olfactory	olfactory	NOUN
fnp-3388	105	10	transmucosal	transmucosal	PROPN
fnp-3388	105	11	sars	sars	PROPN
fnp-3388	105	12	-	-	PUNCT
fnp-3388	105	13	cov-2	cov-2	PART
fnp-3388	105	14	invasion	invasion	NOUN
fnp-3388	105	15	as	as	ADP
fnp-3388	105	16	a	a	DET
fnp-3388	105	17	port	port	NOUN
fnp-3388	105	18	of	of	ADP
fnp-3388	105	19	central	central	ADJ
fnp-3388	105	20	nervous	nervous	ADJ
fnp-3388	105	21	system	system	NOUN
fnp-3388	105	22	entry	entry	NOUN
fnp-3388	105	23	in	in	ADP
fnp-3388	105	24	individuals	individual	NOUN
fnp-3388	105	25	with	with	ADP
fnp-3388	105	26	covid-19	covid-19	PROPN
fnp-3388	105	27	.	.	PUNCT
fnp-3388	106	1	nat	nat	PROPN
fnp-3388	106	2	neurosci	neurosci	PROPN
fnp-3388	106	3	,	,	PUNCT
fnp-3388	106	4	2021	2021	NUM
fnp-3388	106	5	.	.	PUNCT
fnp-3388	107	1	24(2	24(2	NUM
fnp-3388	107	2	):	):	PUNCT
fnp-3388	108	1	p.	p.	NOUN
fnp-3388	108	2	168	168	NUM
fnp-3388	108	3	-	-	SYM
fnp-3388	108	4	175	175	NUM
fnp-3388	108	5	.	.	PUNCT
fnp-3388	108	6	12	12	NUM
fnp-3388	108	7	.	.	PUNCT
fnp-3388	109	1	matschke	matschke	PROPN
fnp-3388	109	2	,	,	PUNCT
fnp-3388	109	3	j.	j.	PROPN
fnp-3388	109	4	,	,	PUNCT
fnp-3388	109	5	et	et	PROPN
fnp-3388	109	6	al	al	PROPN
fnp-3388	109	7	.	.	PROPN
fnp-3388	109	8	,	,	PUNCT
fnp-3388	109	9	neuropathology	neuropathology	NOUN
fnp-3388	109	10	of	of	ADP
fnp-3388	109	11	patients	patient	NOUN
fnp-3388	109	12	with	with	ADP
fnp-3388	109	13	covid-19	covid-19	PROPN
fnp-3388	109	14	in	in	ADP
fnp-3388	109	15	germany	germany	PROPN
fnp-3388	109	16	:	:	PUNCT
fnp-3388	109	17	a	a	DET
fnp-3388	109	18	post	post	ADJ
fnp-3388	109	19	-	-	ADJ
fnp-3388	109	20	mortem	mortem	ADJ
fnp-3388	109	21	case	case	NOUN
fnp-3388	109	22	series	series	NOUN
fnp-3388	109	23	.	.	PUNCT
fnp-3388	110	1	lancet	lancet	PROPN
fnp-3388	110	2	neurol	neurol	PROPN
fnp-3388	110	3	,	,	PUNCT
fnp-3388	110	4	2020	2020	NUM
fnp-3388	110	5	.	.	PUNCT
fnp-3388	111	1	19(11	19(11	NUM
fnp-3388	111	2	):	):	PUNCT
fnp-3388	112	1	p.	p.	NOUN
fnp-3388	112	2	919	919	NUM
fnp-3388	112	3	-	-	SYM
fnp-3388	112	4	929	929	NUM
fnp-3388	112	5	.	.	PUNCT
fnp-3388	112	6	13	13	NUM
fnp-3388	112	7	.	.	PUNCT
fnp-3388	112	8	von	von	PROPN
fnp-3388	112	9	weyhern	weyhern	PROPN
fnp-3388	112	10	,	,	PUNCT
fnp-3388	112	11	c.h	c.h	PROPN
fnp-3388	112	12	.	.	PROPN
fnp-3388	112	13	,	,	PUNCT
fnp-3388	112	14	et	et	PROPN
fnp-3388	112	15	al	al	PROPN
fnp-3388	112	16	.	.	PROPN
fnp-3388	112	17	,	,	PUNCT
fnp-3388	112	18	early	early	ADJ
fnp-3388	112	19	evidence	evidence	NOUN
fnp-3388	112	20	of	of	ADP
fnp-3388	112	21	pronounced	pronounce	VERB
fnp-3388	112	22	brain	brain	NOUN
fnp-3388	112	23	involvement	involvement	NOUN
fnp-3388	112	24	in	in	ADP
fnp-3388	112	25	fatal	fatal	ADJ
fnp-3388	112	26	covid-19	covid-19	PROPN
fnp-3388	112	27	outcomes	outcome	NOUN
fnp-3388	112	28	.	.	PUNCT
fnp-3388	113	1	lancet	lancet	PROPN
fnp-3388	113	2	,	,	PUNCT
fnp-3388	113	3	2020	2020	NUM
fnp-3388	113	4	.	.	PUNCT
fnp-3388	114	1	395(10241	395(10241	NUM
fnp-3388	114	2	):	):	PUNCT
fnp-3388	114	3	p.	p.	NOUN
fnp-3388	114	4	e109	e109	PROPN
fnp-3388	114	5	.	.	PUNCT
fnp-3388	115	1	14	14	NUM
fnp-3388	115	2	.	.	PUNCT
fnp-3388	116	1	solomon	solomon	PROPN
fnp-3388	116	2	,	,	PUNCT
fnp-3388	116	3	i.h	i.h	PROPN
fnp-3388	116	4	.	.	PROPN
fnp-3388	116	5	,	,	PUNCT
fnp-3388	116	6	et	et	PROPN
fnp-3388	116	7	al	al	PROPN
fnp-3388	116	8	.	.	PROPN
fnp-3388	116	9	,	,	PUNCT
fnp-3388	116	10	neuropathological	neuropathological	ADJ
fnp-3388	116	11	features	feature	NOUN
fnp-3388	116	12	of	of	ADP
fnp-3388	116	13	covid-19	covid-19	PROPN
fnp-3388	116	14	.	.	PUNCT
fnp-3388	117	1	n	n	PROPN
fnp-3388	117	2	engl	engl	PROPN
fnp-3388	117	3	j	j	PROPN
fnp-3388	117	4	med	med	PROPN
fnp-3388	117	5	,	,	PUNCT
fnp-3388	117	6	2020	2020	NUM
fnp-3388	117	7	.	.	PUNCT
fnp-3388	118	1	383(10	383(10	NUM
fnp-3388	118	2	):	):	PUNCT
fnp-3388	119	1	p.	p.	NOUN
fnp-3388	119	2	989	989	NUM
fnp-3388	119	3	-	-	SYM
fnp-3388	119	4	992	992	NUM
fnp-3388	119	5	.	.	NOUN
fnp-3388	119	6	15	15	NUM
fnp-3388	119	7	.	.	PUNCT
fnp-3388	119	8	morbini	morbini	PROPN
fnp-3388	119	9	,	,	PUNCT
fnp-3388	119	10	p.	p.	PROPN
fnp-3388	119	11	,	,	PUNCT
fnp-3388	119	12	et	et	PROPN
fnp-3388	119	13	al	al	PROPN
fnp-3388	119	14	.	.	PROPN
fnp-3388	119	15	,	,	PUNCT
fnp-3388	119	16	ultrastructural	ultrastructural	ADJ
fnp-3388	119	17	evidence	evidence	NOUN
fnp-3388	119	18	of	of	ADP
fnp-3388	119	19	direct	direct	ADJ
fnp-3388	119	20	viral	viral	ADJ
fnp-3388	119	21	damage	damage	NOUN
fnp-3388	119	22	to	to	ADP
fnp-3388	119	23	the	the	DET
fnp-3388	119	24	olfactory	olfactory	NOUN
fnp-3388	119	25	complex	complex	NOUN
fnp-3388	119	26	in	in	ADP
fnp-3388	119	27	patients	patient	NOUN
fnp-3388	119	28	testing	test	VERB
fnp-3388	119	29	positive	positive	ADJ
fnp-3388	119	30	for	for	ADP
fnp-3388	119	31	sars	sar	NOUN
fnp-3388	119	32	-	-	PUNCT
fnp-3388	119	33	cov-2	cov-2	NOUN
fnp-3388	119	34	.	.	PUNCT
fnp-3388	120	1	jama	jama	PROPN
fnp-3388	120	2	otolaryngol	otolaryngol	PROPN
fnp-3388	120	3	head	head	NOUN
fnp-3388	120	4	neck	neck	NOUN
fnp-3388	120	5	surg	surg	NOUN
fnp-3388	120	6	,	,	PUNCT
fnp-3388	120	7	2020	2020	NUM
fnp-3388	120	8	.	.	PUNCT
fnp-3388	121	1	146(10	146(10	NUM
fnp-3388	121	2	):	):	PUNCT
fnp-3388	122	1	p.	p.	NOUN
fnp-3388	122	2	972	972	NUM
fnp-3388	122	3	-	-	SYM
fnp-3388	122	4	973	973	NUM
fnp-3388	122	5	.	.	PUNCT
fnp-3388	122	6	16	16	NUM
fnp-3388	122	7	.	.	PUNCT
fnp-3388	123	1	al	al	PROPN
fnp-3388	123	2	-	-	PUNCT
fnp-3388	123	3	dalahmah	dalahmah	PROPN
fnp-3388	123	4	,	,	PUNCT
fnp-3388	123	5	o.	o.	PROPN
fnp-3388	123	6	,	,	PUNCT
fnp-3388	123	7	et	et	PROPN
fnp-3388	123	8	al	al	PROPN
fnp-3388	123	9	.	.	PROPN
fnp-3388	123	10	,	,	PUNCT
fnp-3388	123	11	neuronophagia	neuronophagia	NOUN
fnp-3388	123	12	and	and	CCONJ
fnp-3388	123	13	microglial	microglial	ADJ
fnp-3388	123	14	nodules	nodule	NOUN
fnp-3388	123	15	in	in	ADP
fnp-3388	123	16	a	a	DET
fnp-3388	123	17	sars	sar	NOUN
fnp-3388	123	18	-	-	PUNCT
fnp-3388	123	19	cov-2	cov-2	NOUN
fnp-3388	123	20	patient	patient	NOUN
fnp-3388	123	21	with	with	ADP
fnp-3388	123	22	cerebellar	cerebellar	ADJ
fnp-3388	123	23	hemorrhage	hemorrhage	NOUN
fnp-3388	123	24	.	.	PUNCT
fnp-3388	124	1	acta	acta	PROPN
fnp-3388	124	2	neuropathol	neuropathol	PROPN
fnp-3388	124	3	commun	commun	PROPN
fnp-3388	124	4	,	,	PUNCT
fnp-3388	124	5	2020	2020	NUM
fnp-3388	124	6	.	.	PUNCT
fnp-3388	125	1	8(147	8(147	NUM
fnp-3388	125	2	)	)	PUNCT
fnp-3388	125	3	.	.	PUNCT
fnp-3388	126	1	17	17	NUM
fnp-3388	126	2	.	.	PUNCT
fnp-3388	126	3	song	song	NOUN
fnp-3388	126	4	,	,	PUNCT
fnp-3388	126	5	p.	p.	PROPN
fnp-3388	126	6	,	,	PUNCT
fnp-3388	126	7	et	et	PROPN
fnp-3388	126	8	al	al	PROPN
fnp-3388	126	9	.	.	PROPN
fnp-3388	126	10	,	,	PUNCT
fnp-3388	126	11	cytokine	cytokine	ADJ
fnp-3388	126	12	storm	storm	NOUN
fnp-3388	126	13	induced	induce	VERB
fnp-3388	126	14	by	by	ADP
fnp-3388	126	15	sars	sar	NOUN
fnp-3388	126	16	-	-	PUNCT
fnp-3388	126	17	cov-2	cov-2	NOUN
fnp-3388	126	18	.	.	PUNCT
fnp-3388	127	1	clin	clin	PROPN
fnp-3388	127	2	chim	chim	PROPN
fnp-3388	127	3	acta	acta	PROPN
fnp-3388	127	4	,	,	PUNCT
fnp-3388	127	5	2020	2020	NUM
fnp-3388	127	6	.	.	PUNCT
fnp-3388	128	1	509	509	NUM
fnp-3388	128	2	:	:	PUNCT
fnp-3388	129	1	p.	p.	NOUN
fnp-3388	129	2	280	280	NUM
fnp-3388	129	3	-	-	SYM
fnp-3388	129	4	287	287	NUM
fnp-3388	129	5	.	.	PUNCT
fnp-3388	129	6	18	18	NUM
fnp-3388	129	7	.	.	X
fnp-3388	129	8	goshua	goshua	PROPN
fnp-3388	129	9	,	,	PUNCT
fnp-3388	129	10	g.	g.	PROPN
fnp-3388	129	11	,	,	PUNCT
fnp-3388	129	12	et	et	PROPN
fnp-3388	129	13	al	al	PROPN
fnp-3388	129	14	.	.	PROPN
fnp-3388	129	15	,	,	PUNCT
fnp-3388	129	16	endotheliopathy	endotheliopathy	ADJ
fnp-3388	129	17	in	in	ADP
fnp-3388	129	18	covid-19	covid-19	PROPN
fnp-3388	129	19	-	-	PUNCT
fnp-3388	129	20	associated	associate	VERB
fnp-3388	129	21	coagulopathy	coagulopathy	ADJ
fnp-3388	129	22	:	:	PUNCT
fnp-3388	129	23	evidence	evidence	NOUN
fnp-3388	129	24	from	from	ADP
fnp-3388	129	25	a	a	DET
fnp-3388	129	26	single	single	ADJ
fnp-3388	129	27	-	-	PUNCT
fnp-3388	129	28	centre	centre	NOUN
fnp-3388	129	29	,	,	PUNCT
fnp-3388	129	30	cross	cross	ADJ
fnp-3388	129	31	-	-	ADJ
fnp-3388	129	32	sectional	sectional	ADJ
fnp-3388	129	33	study	study	NOUN
fnp-3388	129	34	.	.	PUNCT
fnp-3388	130	1	lancet	lancet	PROPN
fnp-3388	130	2	haematol	haematol	NOUN
fnp-3388	130	3	,	,	PUNCT
fnp-3388	130	4	2020	2020	NUM
fnp-3388	130	5	.	.	PUNCT
fnp-3388	131	1	7(8	7(8	NUM
fnp-3388	131	2	):	):	PUNCT
fnp-3388	131	3	p.	p.	NOUN
fnp-3388	131	4	e575	e575	PROPN
fnp-3388	131	5	-	-	PUNCT
fnp-3388	131	6	e582	e582	PROPN
fnp-3388	131	7	.	.	PROPN
fnp-3388	132	1	19	19	NUM
fnp-3388	132	2	.	.	NOUN
fnp-3388	132	3	fabbri	fabbri	NOUN
fnp-3388	132	4	,	,	PUNCT
fnp-3388	132	5	v.p	v.p	PROPN
fnp-3388	132	6	.	.	PROPN
fnp-3388	132	7	,	,	PUNCT
fnp-3388	132	8	et	et	PROPN
fnp-3388	132	9	al	al	PROPN
fnp-3388	132	10	.	.	PROPN
fnp-3388	132	11	,	,	PUNCT
fnp-3388	132	12	brain	brain	NOUN
fnp-3388	132	13	ischemic	ischemic	ADJ
fnp-3388	132	14	injury	injury	NOUN
fnp-3388	132	15	in	in	ADP
fnp-3388	132	16	covid-19	covid-19	PROPN
fnp-3388	132	17	-	-	PUNCT
fnp-3388	132	18	infected	infect	VERB
fnp-3388	132	19	patients	patient	NOUN
fnp-3388	132	20	:	:	PUNCT
fnp-3388	132	21	a	a	DET
fnp-3388	132	22	series	series	NOUN
fnp-3388	132	23	of	of	ADP
fnp-3388	132	24	10	10	NUM
fnp-3388	132	25	post	post	ADJ
fnp-3388	132	26	-	-	ADJ
fnp-3388	132	27	mortem	mortem	ADJ
fnp-3388	132	28	cases	case	NOUN
fnp-3388	132	29	.	.	PUNCT
fnp-3388	133	1	brain	brain	NOUN
fnp-3388	133	2	pathol	pathol	NOUN
fnp-3388	133	3	,	,	PUNCT
fnp-3388	133	4	2021	2021	NUM
fnp-3388	133	5	.	.	PUNCT
fnp-3388	134	1	31(1	31(1	NUM
fnp-3388	134	2	):	):	PUNCT
fnp-3388	134	3	p.	p.	NOUN
fnp-3388	134	4	205	205	NUM
fnp-3388	134	5	-	-	SYM
fnp-3388	134	6	210	210	NUM
fnp-3388	134	7	.	.	PUNCT
fnp-3388	135	1	20	20	NUM
fnp-3388	135	2	.	.	PUNCT
fnp-3388	136	1	hernandez	hernandez	PROPN
fnp-3388	136	2	-	-	PUNCT
fnp-3388	136	3	fernandez	fernandez	PROPN
fnp-3388	136	4	,	,	PUNCT
fnp-3388	136	5	f.	f.	PROPN
fnp-3388	136	6	,	,	PUNCT
fnp-3388	136	7	et	et	PROPN
fnp-3388	136	8	al	al	PROPN
fnp-3388	136	9	.	.	PROPN
fnp-3388	136	10	,	,	PUNCT
fnp-3388	136	11	cerebrovascular	cerebrovascular	ADJ
fnp-3388	136	12	disease	disease	NOUN
fnp-3388	136	13	in	in	ADP
fnp-3388	136	14	patients	patient	NOUN
fnp-3388	136	15	with	with	ADP
fnp-3388	136	16	covid-19	covid-19	PROPN
fnp-3388	136	17	:	:	PUNCT
fnp-3388	136	18	neuroimaging	neuroimaging	ADJ
fnp-3388	136	19	,	,	PUNCT
fnp-3388	136	20	histological	histological	ADJ
fnp-3388	136	21	and	and	CCONJ
fnp-3388	136	22	clinical	clinical	ADJ
fnp-3388	136	23	description	description	NOUN
fnp-3388	136	24	.	.	PUNCT
fnp-3388	137	1	brain	brain	NOUN
fnp-3388	137	2	,	,	PUNCT
fnp-3388	137	3	2020	2020	NUM
fnp-3388	137	4	.	.	PUNCT
fnp-3388	138	1	143(10	143(10	NUM
fnp-3388	138	2	):	):	PUNCT
fnp-3388	138	3	p.	p.	NOUN
fnp-3388	138	4	3089	3089	NUM
fnp-3388	138	5	-	-	SYM
fnp-3388	138	6	3103	3103	NUM
fnp-3388	138	7	.	.	PUNCT
fnp-3388	139	1	21	21	NUM
fnp-3388	139	2	.	.	PUNCT
fnp-3388	139	3	parsons	parson	NOUN
fnp-3388	139	4	,	,	PUNCT
fnp-3388	139	5	t.	t.	PROPN
fnp-3388	139	6	,	,	PUNCT
fnp-3388	139	7	et	et	PROPN
fnp-3388	139	8	al	al	PROPN
fnp-3388	139	9	.	.	PROPN
fnp-3388	139	10	,	,	PUNCT
fnp-3388	139	11	covid-19	covid-19	PROPN
fnp-3388	139	12	-	-	PUNCT
fnp-3388	139	13	associated	associate	VERB
fnp-3388	139	14	acute	acute	NOUN
fnp-3388	139	15	disseminated	disseminate	VERB
fnp-3388	139	16	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	139	17	(	(	PUNCT
fnp-3388	139	18	adem	adem	PROPN
fnp-3388	139	19	)	)	PUNCT
fnp-3388	139	20	.	.	PUNCT
fnp-3388	140	1	j	j	PROPN
fnp-3388	140	2	neurol	neurol	PROPN
fnp-3388	140	3	,	,	PUNCT
fnp-3388	140	4	2020	2020	NUM
fnp-3388	140	5	.	.	PUNCT
fnp-3388	141	1	267(10	267(10	NUM
fnp-3388	141	2	):	):	PUNCT
fnp-3388	141	3	p.	p.	NOUN
fnp-3388	141	4	2799	2799	NUM
fnp-3388	141	5	-	-	SYM
fnp-3388	141	6	2802	2802	NUM
fnp-3388	141	7	.	.	PUNCT
fnp-3388	142	1	22	22	NUM
fnp-3388	142	2	.	.	PUNCT
fnp-3388	143	1	novi	novi	PROPN
fnp-3388	143	2	,	,	PUNCT
fnp-3388	143	3	g.	g.	PROPN
fnp-3388	143	4	,	,	PUNCT
fnp-3388	143	5	et	et	PROPN
fnp-3388	143	6	al	al	PROPN
fnp-3388	143	7	.	.	PROPN
fnp-3388	143	8	,	,	PUNCT
fnp-3388	143	9	acute	acute	PROPN
fnp-3388	143	10	disseminated	disseminate	VERB
fnp-3388	143	11	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	143	12	after	after	ADP
fnp-3388	143	13	sars	sar	NOUN
fnp-3388	143	14	-	-	PUNCT
fnp-3388	143	15	cov-2	cov-2	PART
fnp-3388	143	16	infection	infection	NOUN
fnp-3388	143	17	.	.	PUNCT
fnp-3388	144	1	neurol	neurol	PROPN
fnp-3388	144	2	neuroimmunol	neuroimmunol	PROPN
fnp-3388	144	3	neuroinflamm	neuroinflamm	PROPN
fnp-3388	144	4	,	,	PUNCT
fnp-3388	144	5	2020	2020	NUM
fnp-3388	144	6	.	.	PUNCT
fnp-3388	145	1	7(5	7(5	NUM
fnp-3388	145	2	)	)	PUNCT
fnp-3388	145	3	.	.	PUNCT
fnp-3388	146	1	23	23	NUM
fnp-3388	146	2	.	.	PUNCT
fnp-3388	147	1	abdi	abdi	PROPN
fnp-3388	147	2	,	,	PUNCT
fnp-3388	147	3	s.	s.	PROPN
fnp-3388	147	4	,	,	PUNCT
fnp-3388	147	5	a.	a.	NOUN
fnp-3388	147	6	ghorbani	ghorbani	NOUN
fnp-3388	147	7	,	,	PUNCT
fnp-3388	147	8	and	and	CCONJ
fnp-3388	147	9	f.	f.	PROPN
fnp-3388	147	10	fatehi	fatehi	PROPN
fnp-3388	147	11	,	,	PUNCT
fnp-3388	147	12	the	the	DET
fnp-3388	147	13	association	association	NOUN
fnp-3388	147	14	of	of	ADP
fnp-3388	147	15	sars	sars	PROPN
fnp-3388	147	16	-	-	PUNCT
fnp-3388	147	17	cov-2	cov-2	NOUN
fnp-3388	147	18	infection	infection	NOUN
fnp-3388	147	19	and	and	CCONJ
fnp-3388	147	20	acute	acute	NOUN
fnp-3388	147	21	disseminated	disseminate	VERB
fnp-3388	147	22	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	147	23	without	without	ADP
fnp-3388	147	24	prominent	prominent	ADJ
fnp-3388	147	25	clinical	clinical	ADJ
fnp-3388	147	26	pulmonary	pulmonary	ADJ
fnp-3388	147	27	symptoms	symptom	NOUN
fnp-3388	147	28	.	.	PUNCT
fnp-3388	148	1	j	j	PROPN
fnp-3388	148	2	neurol	neurol	PROPN
fnp-3388	148	3	sci	sci	PROPN
fnp-3388	148	4	,	,	PUNCT
fnp-3388	148	5	2020	2020	NUM
fnp-3388	148	6	.	.	PUNCT
fnp-3388	149	1	416	416	NUM
fnp-3388	149	2	:	:	PUNCT
fnp-3388	149	3	p.	p.	NOUN
fnp-3388	149	4	117001	117001	NUM
fnp-3388	149	5	.	.	PUNCT
fnp-3388	150	1	24	24	NUM
fnp-3388	150	2	.	.	X
fnp-3388	150	3	sawlani	sawlani	NOUN
fnp-3388	150	4	,	,	PUNCT
fnp-3388	150	5	v.	v.	ADV
fnp-3388	150	6	,	,	PUNCT
fnp-3388	150	7	et	et	PROPN
fnp-3388	150	8	al	al	PROPN
fnp-3388	150	9	.	.	PROPN
fnp-3388	150	10	,	,	PUNCT
fnp-3388	150	11	covid-19	covid-19	PROPN
fnp-3388	150	12	-	-	PUNCT
fnp-3388	150	13	related	relate	VERB
fnp-3388	150	14	intracranial	intracranial	ADJ
fnp-3388	150	15	imaging	imaging	NOUN
fnp-3388	150	16	findings	finding	NOUN
fnp-3388	150	17	:	:	PUNCT
fnp-3388	150	18	a	a	DET
fnp-3388	150	19	large	large	ADJ
fnp-3388	150	20	single	single	ADJ
fnp-3388	150	21	-	-	PUNCT
fnp-3388	150	22	centre	centre	NOUN
fnp-3388	150	23	experience	experience	NOUN
fnp-3388	150	24	.	.	PUNCT
fnp-3388	151	1	clin	clin	PROPN
fnp-3388	151	2	radiol	radiol	PROPN
fnp-3388	151	3	,	,	PUNCT
fnp-3388	151	4	2021	2021	NUM
fnp-3388	151	5	.	.	PUNCT
fnp-3388	152	1	76(2	76(2	NUM
fnp-3388	152	2	):	):	PUNCT
fnp-3388	153	1	p.	p.	NOUN
fnp-3388	153	2	108	108	NUM
fnp-3388	153	3	-	-	SYM
fnp-3388	153	4	116	116	NUM
fnp-3388	153	5	.	.	PUNCT
fnp-3388	153	6	25	25	NUM
fnp-3388	153	7	.	.	X
fnp-3388	153	8	de	de	PROPN
fnp-3388	153	9	miranda	miranda	PROPN
fnp-3388	153	10	henriques	henriques	PROPN
fnp-3388	153	11	-	-	PUNCT
fnp-3388	153	12	souza	souza	PROPN
fnp-3388	153	13	,	,	PUNCT
fnp-3388	153	14	a.m.	a.m.	ADV
fnp-3388	153	15	,	,	PUNCT
fnp-3388	153	16	et	et	PROPN
fnp-3388	153	17	al	al	PROPN
fnp-3388	153	18	.	.	PROPN
fnp-3388	153	19	,	,	PUNCT
fnp-3388	153	20	acute	acute	PROPN
fnp-3388	153	21	disseminated	disseminate	VERB
fnp-3388	153	22	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	153	23	in	in	ADP
fnp-3388	153	24	a	a	DET
fnp-3388	153	25	covid-19	covid-19	PROPN
fnp-3388	153	26	pediatric	pediatric	ADJ
fnp-3388	153	27	patient	patient	NOUN
fnp-3388	153	28	.	.	PUNCT
fnp-3388	154	1	neuroradiology	neuroradiology	NOUN
fnp-3388	154	2	,	,	PUNCT
fnp-3388	154	3	2021	2021	NUM
fnp-3388	154	4	.	.	PUNCT
fnp-3388	155	1	63(1	63(1	NUM
fnp-3388	155	2	):	):	PUNCT
fnp-3388	156	1	p.	p.	NOUN
fnp-3388	156	2	141	141	NUM
fnp-3388	156	3	-	-	SYM
fnp-3388	156	4	145	145	NUM
fnp-3388	156	5	.	.	PUNCT
fnp-3388	156	6	26	26	NUM
fnp-3388	156	7	.	.	PUNCT
fnp-3388	157	1	yong	yong	PROPN
fnp-3388	157	2	,	,	PUNCT
fnp-3388	157	3	m.h	m.h	PROPN
fnp-3388	157	4	.	.	PROPN
fnp-3388	157	5	,	,	PUNCT
fnp-3388	157	6	et	et	PROPN
fnp-3388	157	7	al	al	PROPN
fnp-3388	157	8	.	.	PROPN
fnp-3388	157	9	,	,	PUNCT
fnp-3388	157	10	a	a	DET
fnp-3388	157	11	rare	rare	ADJ
fnp-3388	157	12	case	case	NOUN
fnp-3388	157	13	of	of	ADP
fnp-3388	157	14	acute	acute	ADJ
fnp-3388	157	15	hemorrhagic	hemorrhagic	NOUN
fnp-3388	157	16	leukoencephalitis	leukoencephaliti	VERB
fnp-3388	157	17	in	in	ADP
fnp-3388	157	18	a	a	DET
fnp-3388	157	19	covid-19	covid-19	PROPN
fnp-3388	157	20	patient	patient	NOUN
fnp-3388	157	21	.	.	PUNCT
fnp-3388	158	1	j	j	PROPN
fnp-3388	158	2	neurol	neurol	PROPN
fnp-3388	158	3	sci	sci	PROPN
fnp-3388	158	4	,	,	PUNCT
fnp-3388	158	5	2020	2020	NUM
fnp-3388	158	6	.	.	PUNCT
fnp-3388	159	1	416	416	NUM
fnp-3388	159	2	:	:	PUNCT
fnp-3388	160	1	p.	p.	NOUN
fnp-3388	160	2	117035	117035	NUM
fnp-3388	160	3	.	.	PUNCT
fnp-3388	161	1	27	27	NUM
fnp-3388	161	2	.	.	X
fnp-3388	161	3	umapathi	umapathi	NOUN
fnp-3388	161	4	,	,	PUNCT
fnp-3388	161	5	t.	t.	PROPN
fnp-3388	161	6	,	,	PUNCT
fnp-3388	161	7	et	et	PROPN
fnp-3388	161	8	al	al	PROPN
fnp-3388	161	9	.	.	PROPN
fnp-3388	161	10	,	,	PUNCT
fnp-3388	161	11	encephalopathy	encephalopathy	ADJ
fnp-3388	161	12	in	in	ADP
fnp-3388	161	13	covid-19	covid-19	PROPN
fnp-3388	161	14	patients	patient	NOUN
fnp-3388	161	15	;	;	PUNCT
fnp-3388	161	16	viral	viral	ADJ
fnp-3388	161	17	,	,	PUNCT
fnp-3388	161	18	parainfectious	parainfectious	ADJ
fnp-3388	161	19	,	,	PUNCT
fnp-3388	161	20	or	or	CCONJ
fnp-3388	161	21	both	both	PRON
fnp-3388	161	22	?	?	PUNCT
fnp-3388	162	1	eneurologicalsci	eneurologicalsci	NOUN
fnp-3388	162	2	,	,	PUNCT
fnp-3388	162	3	2020	2020	NUM
fnp-3388	162	4	.	.	PUNCT
fnp-3388	163	1	21	21	NUM
fnp-3388	163	2	:	:	PUNCT
fnp-3388	163	3	p.	p.	NOUN
fnp-3388	163	4	100275	100275	NUM
fnp-3388	163	5	.	.	PUNCT
fnp-3388	164	1	28	28	NUM
fnp-3388	164	2	.	.	PUNCT
fnp-3388	165	1	mccuddy	mccuddy	PROPN
fnp-3388	165	2	,	,	PUNCT
fnp-3388	165	3	m.	m.	NOUN
fnp-3388	165	4	,	,	PUNCT
fnp-3388	165	5	et	et	PROPN
fnp-3388	165	6	al	al	PROPN
fnp-3388	165	7	.	.	PROPN
fnp-3388	165	8	,	,	PUNCT
fnp-3388	165	9	acute	acute	ADJ
fnp-3388	165	10	demyelinating	demyelinate	VERB
fnp-3388	165	11	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	165	12	(	(	PUNCT
fnp-3388	165	13	adem	adem	PROPN
fnp-3388	165	14	)	)	PUNCT
fnp-3388	165	15	in	in	ADP
fnp-3388	165	16	covid-19	covid-19	PROPN
fnp-3388	165	17	infection	infection	NOUN
fnp-3388	165	18	:	:	PUNCT
fnp-3388	165	19	a	a	DET
fnp-3388	165	20	case	case	NOUN
fnp-3388	165	21	series	series	NOUN
fnp-3388	165	22	.	.	PUNCT
fnp-3388	166	1	neurol	neurol	PROPN
fnp-3388	166	2	india	india	PROPN
fnp-3388	166	3	,	,	PUNCT
fnp-3388	166	4	2020	2020	NUM
fnp-3388	166	5	.	.	PUNCT
fnp-3388	167	1	68(5	68(5	NUM
fnp-3388	167	2	):	):	PUNCT
fnp-3388	167	3	p.	p.	NOUN
fnp-3388	167	4	1192	1192	NUM
fnp-3388	167	5	-	-	SYM
fnp-3388	167	6	1195	1195	NUM
fnp-3388	167	7	.	.	PUNCT
fnp-3388	168	1	29	29	NUM
fnp-3388	168	2	.	.	X
fnp-3388	169	1	lopes	lope	NOUN
fnp-3388	169	2	,	,	PUNCT
fnp-3388	169	3	c.c.b	c.c.b	NOUN
fnp-3388	169	4	.	.	PUNCT
fnp-3388	169	5	,	,	PUNCT
fnp-3388	169	6	et	et	PROPN
fnp-3388	169	7	al	al	PROPN
fnp-3388	169	8	.	.	PROPN
fnp-3388	169	9	,	,	PUNCT
fnp-3388	169	10	acute	acute	PROPN
fnp-3388	169	11	disseminated	disseminate	VERB
fnp-3388	169	12	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	169	13	in	in	ADP
fnp-3388	169	14	covid-19	covid-19	PROPN
fnp-3388	169	15	:	:	PUNCT
fnp-3388	169	16	presentation	presentation	NOUN
fnp-3388	169	17	of	of	ADP
fnp-3388	169	18	two	two	NUM
fnp-3388	169	19	cases	case	NOUN
fnp-3388	169	20	and	and	CCONJ
fnp-3388	169	21	review	review	NOUN
fnp-3388	169	22	of	of	ADP
fnp-3388	169	23	the	the	DET
fnp-3388	169	24	literature	literature	NOUN
fnp-3388	169	25	.	.	PUNCT
fnp-3388	169	26	arq	arq	VERB
fnp-3388	169	27	neuropsiquiatr	neuropsiquiatr	ADJ
fnp-3388	169	28	,	,	PUNCT
fnp-3388	169	29	2020	2020	NUM
fnp-3388	169	30	.	.	PUNCT
fnp-3388	170	1	78(12	78(12	NUM
fnp-3388	170	2	):	):	PUNCT
fnp-3388	171	1	p.	p.	NOUN
fnp-3388	171	2	805	805	NUM
fnp-3388	171	3	-	-	SYM
fnp-3388	171	4	810	810	NUM
fnp-3388	171	5	.	.	PUNCT
fnp-3388	171	6	30	30	NUM
fnp-3388	171	7	.	.	PUNCT
fnp-3388	172	1	langley	langley	PROPN
fnp-3388	172	2	,	,	PUNCT
fnp-3388	172	3	l.	l.	PROPN
fnp-3388	172	4	,	,	PUNCT
fnp-3388	172	5	et	et	PROPN
fnp-3388	172	6	al	al	PROPN
fnp-3388	172	7	.	.	PROPN
fnp-3388	172	8	,	,	PUNCT
fnp-3388	172	9	acute	acute	PROPN
fnp-3388	172	10	disseminated	disseminate	VERB
fnp-3388	172	11	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	172	12	(	(	PUNCT
fnp-3388	172	13	adem	adem	PROPN
fnp-3388	172	14	)	)	PUNCT
fnp-3388	172	15	associated	associate	VERB
fnp-3388	172	16	with	with	ADP
fnp-3388	172	17	covid-19	covid-19	PROPN
fnp-3388	172	18	.	.	PUNCT
fnp-3388	173	1	bmj	bmj	PROPN
fnp-3388	173	2	case	case	NOUN
fnp-3388	173	3	rep	rep	PROPN
fnp-3388	173	4	,	,	PUNCT
fnp-3388	173	5	2020	2020	NUM
fnp-3388	173	6	.	.	PUNCT
fnp-3388	174	1	13(12	13(12	NUM
fnp-3388	174	2	)	)	PUNCT
fnp-3388	174	3	.	.	PUNCT
fnp-3388	175	1	31	31	NUM
fnp-3388	175	2	.	.	PUNCT
fnp-3388	176	1	handa	handa	PROPN
fnp-3388	176	2	,	,	PUNCT
fnp-3388	176	3	r.	r.	PROPN
fnp-3388	176	4	,	,	PUNCT
fnp-3388	176	5	et	et	PROPN
fnp-3388	176	6	al	al	PROPN
fnp-3388	176	7	.	.	PROPN
fnp-3388	176	8	,	,	PUNCT
fnp-3388	176	9	covid-19	covid-19	PROPN
fnp-3388	176	10	-	-	PUNCT
fnp-3388	176	11	associated	associate	VERB
fnp-3388	176	12	acute	acute	ADJ
fnp-3388	176	13	haemorrhagic	haemorrhagic	NOUN
fnp-3388	176	14	leukoencephalomyelitis	leukoencephalomyelitis	NOUN
fnp-3388	176	15	.	.	PUNCT
fnp-3388	177	1	neurol	neurol	PROPN
fnp-3388	177	2	sci	sci	PROPN
fnp-3388	177	3	,	,	PUNCT
fnp-3388	177	4	2020	2020	NUM
fnp-3388	177	5	.	.	PUNCT
fnp-3388	178	1	41(11	41(11	NUM
fnp-3388	178	2	):	):	PUNCT
fnp-3388	178	3	p.	p.	NOUN
fnp-3388	178	4	3023	3023	NUM
fnp-3388	178	5	-	-	SYM
fnp-3388	178	6	3026	3026	NUM
fnp-3388	178	7	.	.	PUNCT
fnp-3388	179	1	32	32	NUM
fnp-3388	179	2	.	.	X
fnp-3388	179	3	reichard	reichard	PROPN
fnp-3388	179	4	,	,	PUNCT
fnp-3388	179	5	r.r	r.r	PROPN
fnp-3388	179	6	.	.	PROPN
fnp-3388	179	7	,	,	PUNCT
fnp-3388	179	8	et	et	PROPN
fnp-3388	179	9	al	al	PROPN
fnp-3388	179	10	.	.	PROPN
fnp-3388	179	11	,	,	PUNCT
fnp-3388	179	12	neuropathology	neuropathology	NOUN
fnp-3388	179	13	of	of	ADP
fnp-3388	179	14	covid-19	covid-19	PROPN
fnp-3388	179	15	:	:	PUNCT
fnp-3388	179	16	a	a	DET
fnp-3388	179	17	spectrum	spectrum	NOUN
fnp-3388	179	18	of	of	ADP
fnp-3388	179	19	vascular	vascular	NOUN
fnp-3388	179	20	and	and	CCONJ
fnp-3388	179	21	acute	acute	ADJ
fnp-3388	179	22	disseminated	disseminate	VERB
fnp-3388	179	23	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	179	24	(	(	PUNCT
fnp-3388	179	25	adem)-like	adem)-like	ADP
fnp-3388	179	26	pathology	pathology	NOUN
fnp-3388	179	27	.	.	PUNCT
fnp-3388	180	1	acta	acta	PROPN
fnp-3388	180	2	neuropathol	neuropathol	PROPN
fnp-3388	180	3	,	,	PUNCT
fnp-3388	180	4	2020	2020	NUM
fnp-3388	180	5	.	.	PUNCT
fnp-3388	181	1	140(1	140(1	NUM
fnp-3388	181	2	):	):	PUNCT
fnp-3388	181	3	p.	p.	NOUN
fnp-3388	181	4	1	1	NUM
fnp-3388	181	5	-	-	SYM
fnp-3388	181	6	6	6	NUM
fnp-3388	181	7	.	.	X
fnp-3388	181	8	33	33	NUM
fnp-3388	181	9	.	.	X
fnp-3388	181	10	walker	walker	PROPN
fnp-3388	181	11	,	,	PUNCT
fnp-3388	181	12	j.m	j.m	PROPN
fnp-3388	181	13	.	.	PROPN
fnp-3388	181	14	,	,	PUNCT
fnp-3388	181	15	et	et	PROPN
fnp-3388	181	16	al	al	PROPN
fnp-3388	181	17	.	.	PROPN
fnp-3388	181	18	,	,	PUNCT
fnp-3388	181	19	covid-19	covid-19	PROPN
fnp-3388	181	20	patients	patient	NOUN
fnp-3388	181	21	with	with	ADP
fnp-3388	181	22	cns	cns	PROPN
fnp-3388	181	23	complications	complication	NOUN
fnp-3388	181	24	and	and	CCONJ
fnp-3388	181	25	neuropathologic	neuropathologic	ADJ
fnp-3388	181	26	features	feature	NOUN
fnp-3388	181	27	of	of	ADP
fnp-3388	181	28	acute	acute	NOUN
fnp-3388	181	29	disseminated	disseminate	VERB
fnp-3388	181	30	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	181	31	and	and	CCONJ
fnp-3388	181	32	acute	acute	ADJ
fnp-3388	181	33	hemorrhagic	hemorrhagic	NOUN
fnp-3388	181	34	leukoencephalopathy	leukoencephalopathy	NOUN
fnp-3388	181	35	.	.	PUNCT
fnp-3388	182	1	j	j	PROPN
fnp-3388	182	2	neuropathol	neuropathol	PROPN
fnp-3388	182	3	exp	exp	PROPN
fnp-3388	182	4	neurol	neurol	NOUN
fnp-3388	182	5	,	,	PUNCT
fnp-3388	182	6	2021	2021	NUM
fnp-3388	182	7	.	.	PUNCT
fnp-3388	183	1	34	34	NUM
fnp-3388	183	2	.	.	PUNCT
fnp-3388	184	1	bryce	bryce	PROPN
fnp-3388	184	2	,	,	PUNCT
fnp-3388	184	3	c.	c.	PROPN
fnp-3388	184	4	,	,	PUNCT
fnp-3388	184	5	et	et	PROPN
fnp-3388	184	6	al	al	PROPN
fnp-3388	184	7	.	.	PROPN
fnp-3388	184	8	,	,	PUNCT
fnp-3388	184	9	pathophysiology	pathophysiology	NOUN
fnp-3388	184	10	of	of	ADP
fnp-3388	184	11	sars	sar	NOUN
fnp-3388	184	12	-	-	PUNCT
fnp-3388	184	13	cov-2	cov-2	NUM
fnp-3388	184	14	:	:	PUNCT
fnp-3388	184	15	the	the	DET
fnp-3388	184	16	mount	mount	PROPN
fnp-3388	184	17	sinai	sinai	PROPN
fnp-3388	184	18	covid-19	covid-19	PROPN
fnp-3388	184	19	autopsy	autopsy	ADJ
fnp-3388	184	20	experience	experience	NOUN
fnp-3388	184	21	.	.	PUNCT
fnp-3388	185	1	mod	mod	PROPN
fnp-3388	185	2	pathol	pathol	PROPN
fnp-3388	185	3	,	,	PUNCT
fnp-3388	185	4	2021	2021	NUM
fnp-3388	185	5	.	.	PUNCT
fnp-3388	186	1	35	35	NUM
fnp-3388	186	2	.	.	PUNCT
fnp-3388	186	3	cole	cole	PROPN
fnp-3388	186	4	,	,	PUNCT
fnp-3388	186	5	j.	j.	PROPN
fnp-3388	186	6	,	,	PUNCT
fnp-3388	186	7	et	et	PROPN
fnp-3388	186	8	al	al	PROPN
fnp-3388	186	9	.	.	PROPN
fnp-3388	186	10	,	,	PUNCT
fnp-3388	186	11	acute	acute	PROPN
fnp-3388	186	12	disseminated	disseminate	VERB
fnp-3388	186	13	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	186	14	in	in	ADP
fnp-3388	186	15	children	child	NOUN
fnp-3388	186	16	:	:	PUNCT
fnp-3388	186	17	an	an	DET
fnp-3388	186	18	updated	update	VERB
fnp-3388	186	19	review	review	NOUN
fnp-3388	186	20	based	base	VERB
fnp-3388	186	21	on	on	ADP
fnp-3388	186	22	current	current	ADJ
fnp-3388	186	23	diagnostic	diagnostic	ADJ
fnp-3388	186	24	criteria	criterion	NOUN
fnp-3388	186	25	.	.	PUNCT
fnp-3388	187	1	pediatr	pediatr	ADJ
fnp-3388	187	2	neurol	neurol	NOUN
fnp-3388	187	3	,	,	PUNCT
fnp-3388	187	4	2019	2019	NUM
fnp-3388	187	5	.	.	PUNCT
fnp-3388	188	1	100	100	NUM
fnp-3388	188	2	:	:	PUNCT
fnp-3388	188	3	p.	p.	NOUN
fnp-3388	188	4	26	26	NUM
fnp-3388	188	5	-	-	SYM
fnp-3388	188	6	34	34	NUM
fnp-3388	188	7	.	.	PUNCT
fnp-3388	188	8	36	36	NUM
fnp-3388	188	9	.	.	PUNCT
fnp-3388	189	1	mclendon	mclendon	PROPN
fnp-3388	189	2	,	,	PUNCT
fnp-3388	189	3	l.a	l.a	PROPN
fnp-3388	189	4	.	.	PROPN
fnp-3388	189	5	,	,	PUNCT
fnp-3388	189	6	et	et	PROPN
fnp-3388	189	7	al	al	PROPN
fnp-3388	189	8	.	.	PROPN
fnp-3388	189	9	,	,	PUNCT
fnp-3388	189	10	post	post	ADJ
fnp-3388	189	11	-	-	ADJ
fnp-3388	189	12	covid-19	covid-19	ADJ
fnp-3388	189	13	acute	acute	NOUN
fnp-3388	189	14	disseminated	disseminate	VERB
fnp-3388	189	15	encephalomyelitis	encephalomyelitis	NOUN
fnp-3388	189	16	in	in	ADP
fnp-3388	189	17	a	a	DET
fnp-3388	189	18	17	17	NUM
fnp-3388	189	19	-	-	PUNCT
fnp-3388	189	20	month	month	NOUN
fnp-3388	189	21	-	-	PUNCT
fnp-3388	189	22	old	old	ADJ
fnp-3388	189	23	.	.	PUNCT
fnp-3388	189	24	pediatrics	pediatric	NOUN
fnp-3388	189	25	,	,	PUNCT
fnp-3388	189	26	2021	2021	NUM
fnp-3388	189	27	.	.	PUNCT
fnp-3388	190	1	147(6	147(6	NUM
fnp-3388	190	2	)	)	PUNCT
fnp-3388	190	3	.	.	PUNCT
fnp-3388	191	1	37	37	NUM
fnp-3388	191	2	.	.	PUNCT
fnp-3388	192	1	vraka	vraka	PROPN
fnp-3388	192	2	,	,	PUNCT
fnp-3388	192	3	k.	k.	PROPN
fnp-3388	192	4	,	,	PUNCT
fnp-3388	192	5	et	et	PROPN
fnp-3388	192	6	al	al	PROPN
fnp-3388	192	7	.	.	PROPN
fnp-3388	192	8	,	,	PUNCT
fnp-3388	192	9	two	two	NUM
fnp-3388	192	10	paediatric	paediatric	ADJ
fnp-3388	192	11	patients	patient	NOUN
fnp-3388	192	12	with	with	ADP
fnp-3388	192	13	encephalopathy	encephalopathy	NOUN
fnp-3388	192	14	and	and	CCONJ
fnp-3388	192	15	concurrent	concurrent	ADJ
fnp-3388	192	16	covid-19	covid-19	PROPN
fnp-3388	192	17	infection	infection	NOUN
fnp-3388	192	18	:	:	PUNCT
fnp-3388	192	19	two	two	NUM
fnp-3388	192	20	sides	side	NOUN
fnp-3388	192	21	of	of	ADP
fnp-3388	192	22	the	the	DET
fnp-3388	192	23	same	same	ADJ
fnp-3388	192	24	coin	coin	NOUN
fnp-3388	192	25	?	?	PUNCT
fnp-3388	193	1	case	case	NOUN
fnp-3388	193	2	rep	rep	PROPN
fnp-3388	193	3	neurol	neurol	PROPN
fnp-3388	193	4	med	me	VERB
fnp-3388	193	5	,	,	PUNCT
fnp-3388	193	6	2021	2021	NUM
fnp-3388	193	7	.	.	PUNCT
fnp-3388	194	1	2021	2021	NUM
fnp-3388	194	2	:	:	PUNCT
fnp-3388	195	1	p.	p.	NOUN
fnp-3388	195	2	6658000	6658000	NUM
fnp-3388	195	3	.	.	PUNCT
fnp-3388	196	1	38	38	NUM
fnp-3388	196	2	.	.	PUNCT
fnp-3388	196	3	wong	wong	PROPN
fnp-3388	196	4	,	,	PUNCT
fnp-3388	196	5	a.m.	a.m.	ADV
fnp-3388	196	6	,	,	PUNCT
fnp-3388	196	7	et	et	PROPN
fnp-3388	196	8	al	al	PROPN
fnp-3388	196	9	.	.	PROPN
fnp-3388	196	10	,	,	PUNCT
fnp-3388	196	11	acute	acute	ADJ
fnp-3388	196	12	necrotizing	necrotizing	NOUN
fnp-3388	196	13	encephalopathy	encephalopathy	NOUN
fnp-3388	196	14	of	of	ADP
fnp-3388	196	15	childhood	childhood	NOUN
fnp-3388	196	16	:	:	PUNCT
fnp-3388	196	17	correlation	correlation	NOUN
fnp-3388	196	18	of	of	ADP
fnp-3388	196	19	mr	mr	PROPN
fnp-3388	196	20	findings	finding	NOUN
fnp-3388	196	21	and	and	CCONJ
fnp-3388	196	22	clinical	clinical	ADJ
fnp-3388	196	23	outcome	outcome	NOUN
fnp-3388	196	24	.	.	PUNCT
fnp-3388	197	1	ajnr	ajnr	PROPN
fnp-3388	197	2	am	be	AUX
fnp-3388	197	3	j	j	PROPN
fnp-3388	197	4	neuroradiol	neuroradiol	PROPN
fnp-3388	197	5	,	,	PUNCT
fnp-3388	197	6	2006	2006	NUM
fnp-3388	197	7	.	.	PUNCT
fnp-3388	198	1	27(9	27(9	NUM
fnp-3388	198	2	):	):	PUNCT
fnp-3388	198	3	p.	p.	NOUN
fnp-3388	198	4	1919	1919	NUM
fnp-3388	198	5	-	-	SYM
fnp-3388	198	6	23	23	NUM
fnp-3388	198	7	.	.	NOUN
fnp-3388	198	8	39	39	NUM
fnp-3388	198	9	.	.	PUNCT
fnp-3388	199	1	mizuguchi	mizuguchi	PROPN
fnp-3388	199	2	,	,	PUNCT
fnp-3388	199	3	m.	m.	NOUN
fnp-3388	199	4	,	,	PUNCT
fnp-3388	199	5	acute	acute	ADJ
fnp-3388	199	6	necrotizing	necrotizing	NOUN
fnp-3388	199	7	encephalopathy	encephalopathy	NOUN
fnp-3388	199	8	of	of	ADP
fnp-3388	199	9	childhood	childhood	NOUN
fnp-3388	199	10	:	:	PUNCT
fnp-3388	199	11	a	a	DET
fnp-3388	199	12	novel	novel	ADJ
fnp-3388	199	13	form	form	NOUN
fnp-3388	199	14	of	of	ADP
fnp-3388	199	15	acute	acute	ADJ
fnp-3388	199	16	encephalopathy	encephalopathy	ADJ
fnp-3388	199	17	prevalent	prevalent	NOUN
fnp-3388	199	18	in	in	ADP
fnp-3388	199	19	japan	japan	PROPN
fnp-3388	199	20	and	and	CCONJ
fnp-3388	199	21	taiwan	taiwan	PROPN
fnp-3388	199	22	.	.	PUNCT
fnp-3388	200	1	brain	brain	PROPN
fnp-3388	200	2	dev	dev	PROPN
fnp-3388	200	3	,	,	PUNCT
fnp-3388	200	4	1997	1997	NUM
fnp-3388	200	5	.	.	PUNCT
fnp-3388	201	1	19(2	19(2	NUM
fnp-3388	201	2	):	):	PUNCT
fnp-3388	201	3	p.	p.	NOUN
fnp-3388	201	4	81	81	NUM
fnp-3388	201	5	-	-	SYM
fnp-3388	201	6	92	92	NUM
fnp-3388	201	7	.	.	PUNCT
fnp-3388	201	8	40	40	NUM
fnp-3388	201	9	.	.	PUNCT
fnp-3388	202	1	lazarte	lazarte	NOUN
fnp-3388	202	2	-	-	PUNCT
fnp-3388	202	3	rantes	rantes	PROPN
fnp-3388	202	4	,	,	PUNCT
fnp-3388	202	5	c.	c.	PROPN
fnp-3388	202	6	,	,	PUNCT
fnp-3388	202	7	et	et	PROPN
fnp-3388	202	8	al	al	PROPN
fnp-3388	202	9	.	.	PROPN
fnp-3388	202	10	,	,	PUNCT
fnp-3388	202	11	acute	acute	ADJ
fnp-3388	202	12	necrotizing	necrotizing	NOUN
fnp-3388	202	13	encephalopathy	encephalopathy	NOUN
fnp-3388	202	14	associated	associate	VERB
fnp-3388	202	15	with	with	ADP
fnp-3388	202	16	sars	sar	NOUN
fnp-3388	202	17	-	-	PUNCT
fnp-3388	202	18	cov-2	cov-2	NOUN
fnp-3388	202	19	exposure	exposure	NOUN
fnp-3388	202	20	in	in	ADP
fnp-3388	202	21	a	a	DET
fnp-3388	202	22	pediatric	pediatric	ADJ
fnp-3388	202	23	patient	patient	NOUN
fnp-3388	202	24	.	.	PUNCT
fnp-3388	203	1	cureus	cureus	NOUN
fnp-3388	203	2	,	,	PUNCT
fnp-3388	203	3	2021	2021	NUM
fnp-3388	203	4	.	.	PUNCT
fnp-3388	204	1	13(5	13(5	NUM
fnp-3388	204	2	):	):	PUNCT
fnp-3388	204	3	p.	p.	NOUN
fnp-3388	204	4	e15018	e15018	PROPN
fnp-3388	204	5	.	.	PUNCT
fnp-3388	205	1	41	41	NUM
fnp-3388	205	2	.	.	PUNCT
fnp-3388	206	1	kumar	kumar	PROPN
fnp-3388	206	2	,	,	PUNCT
fnp-3388	206	3	n.	n.	PROPN
fnp-3388	206	4	,	,	PUNCT
fnp-3388	206	5	et	et	PROPN
fnp-3388	206	6	al	al	PROPN
fnp-3388	206	7	.	.	PROPN
fnp-3388	206	8	,	,	PUNCT
fnp-3388	206	9	acute	acute	ADJ
fnp-3388	206	10	necrotizing	necrotizing	NOUN
fnp-3388	206	11	encephalitis	encephalitis	NOUN
fnp-3388	206	12	as	as	ADP
fnp-3388	206	13	a	a	DET
fnp-3388	206	14	probable	probable	ADJ
fnp-3388	206	15	association	association	NOUN
fnp-3388	206	16	of	of	ADP
fnp-3388	206	17	covid-19	covid-19	PROPN
fnp-3388	206	18	.	.	PUNCT
fnp-3388	207	1	indian	indian	PROPN
fnp-3388	207	2	j	j	PROPN
fnp-3388	207	3	crit	crit	PROPN
fnp-3388	207	4	care	care	PROPN
fnp-3388	207	5	med	me	VERB
fnp-3388	207	6	,	,	PUNCT
fnp-3388	207	7	2020	2020	NUM
fnp-3388	207	8	.	.	PUNCT
fnp-3388	208	1	24(10	24(10	NUM
fnp-3388	208	2	):	):	PUNCT
fnp-3388	208	3	p.	p.	NOUN
fnp-3388	208	4	991	991	NUM
fnp-3388	208	5	-	-	SYM
fnp-3388	208	6	994	994	NUM
fnp-3388	208	7	.	.	PUNCT
fnp-3388	209	1	copyright	copyright	NOUN
fnp-3388	209	2	:	:	PUNCT
fnp-3388	209	3	©	©	PROPN
fnp-3388	209	4	2021	2021	NUM
fnp-3388	209	5	the	the	DET
fnp-3388	209	6	author(s	author(s	NOUN
fnp-3388	209	7	)	)	PUNCT
fnp-3388	209	8	.	.	PUNCT
fnp-3388	210	1	this	this	PRON
fnp-3388	210	2	is	be	AUX
fnp-3388	210	3	an	an	DET
fnp-3388	210	4	open	open	ADJ
fnp-3388	210	5	access	access	NOUN
fnp-3388	210	6	article	article	NOUN
fnp-3388	210	7	distributed	distribute	VERB
fnp-3388	210	8	under	under	ADP
fnp-3388	210	9	the	the	DET
fnp-3388	210	10	terms	term	NOUN
fnp-3388	210	11	of	of	ADP
fnp-3388	210	12	the	the	DET
fnp-3388	210	13	creative	creative	ADJ
fnp-3388	210	14	commons	common	NOUN
fnp-3388	210	15	attribution	attribution	NOUN
fnp-3388	210	16	4.0	4.0	NUM
fnp-3388	210	17	international	international	ADJ
fnp-3388	210	18	license	license	NOUN
fnp-3388	210	19	(	(	PUNCT
fnp-3388	210	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-3388	210	21	)	)	PUNCT
fnp-3388	210	22	,	,	PUNCT
fnp-3388	210	23	which	which	PRON
fnp-3388	210	24	permits	permit	VERB
fnp-3388	210	25	unrestricted	unrestricted	ADJ
fnp-3388	210	26	use	use	NOUN
fnp-3388	210	27	,	,	PUNCT
fnp-3388	210	28	distribution	distribution	NOUN
fnp-3388	210	29	,	,	PUNCT
fnp-3388	210	30	and	and	CCONJ
fnp-3388	210	31	reproduction	reproduction	NOUN
fnp-3388	210	32	in	in	ADP
fnp-3388	210	33	any	any	DET
fnp-3388	210	34	medium	medium	NOUN
fnp-3388	210	35	,	,	PUNCT
fnp-3388	210	36	provided	provide	VERB
fnp-3388	210	37	the	the	DET
fnp-3388	210	38	original	original	ADJ
fnp-3388	210	39	author	author	NOUN
fnp-3388	210	40	and	and	CCONJ
fnp-3388	210	41	source	source	NOUN
fnp-3388	210	42	are	be	AUX
fnp-3388	210	43	credited	credit	VERB
fnp-3388	210	44	,	,	PUNCT
fnp-3388	210	45	a	a	DET
fnp-3388	210	46	link	link	NOUN
fnp-3388	210	47	to	to	ADP
fnp-3388	210	48	the	the	DET
fnp-3388	210	49	creative	creative	ADJ
fnp-3388	210	50	commons	common	NOUN
fnp-3388	210	51	license	license	NOUN
fnp-3388	210	52	is	be	AUX
fnp-3388	210	53	provided	provide	VERB
fnp-3388	210	54	,	,	PUNCT
fnp-3388	210	55	and	and	CCONJ
fnp-3388	210	56	any	any	DET
fnp-3388	210	57	changes	change	NOUN
fnp-3388	210	58	are	be	AUX
fnp-3388	210	59	indicated	indicate	VERB
fnp-3388	210	60	.	.	PUNCT
fnp-3388	211	1	the	the	DET
fnp-3388	211	2	creative	creative	ADJ
fnp-3388	211	3	commons	common	NOUN
fnp-3388	211	4	public	public	ADJ
fnp-3388	211	5	domain	domain	NOUN
fnp-3388	211	6	dedication	dedication	NOUN
fnp-3388	211	7	waiver	waiver	NOUN
fnp-3388	211	8	(	(	PUNCT
fnp-3388	211	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-3388	211	10	)	)	PUNCT
fnp-3388	211	11	applies	apply	VERB
fnp-3388	211	12	to	to	ADP
fnp-3388	211	13	the	the	DET
fnp-3388	211	14	data	datum	NOUN
fnp-3388	211	15	made	make	VERB
fnp-3388	211	16	available	available	ADJ
fnp-3388	211	17	in	in	ADP
fnp-3388	211	18	this	this	DET
fnp-3388	211	19	article	article	NOUN
fnp-3388	211	20	,	,	PUNCT
fnp-3388	211	21	unless	unless	SCONJ
fnp-3388	211	22	otherwise	otherwise	ADV
fnp-3388	211	23	stated	state	VERB
fnp-3388	211	24	.	.	PUNCT